Qual é o código de barras de TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY?

O código de barras (GTIN/EAN) de TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY é 7896422501651.

De qual marca é o código de barras 7896422501651?

O código 7896422501651 pertence a TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY, da marca MEDLEY.

Qual é o NCM de TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY?

O NCM de TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY é 30039034 (Ácido o-acetilsalicílico; o-acetilsalicilato de alumínio; salicilato de metila; diclorvós).

Em que país foi registrado o código de barras 7896422501651?

O prefixo GS1 789 indica registro em Brasil. O prefixo mostra onde o código foi registrado, não necessariamente onde o produto foi fabricado.

Início
/
Produtos Farmacêuticos
/
Saúde Do Homem
/
MEDLEY
/
TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY

✓ Produto localizado
Produtos Farmacêuticos

TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY

MEDLEY

GTIN / EAN: 7896422501651
NCM: 30039034
CEST: Não informado
Conteúdo: Não informado

Dados de produto preservados no idioma original.

TADALAFILA DIÁRIO 5MG C/ 30 COMPRIMIDOS GENÉRICO MEDLEY é fabricado pela MEDLEY, na categoria Produtos Farmacêuticos, com código de barras 7896422501651. Classificado no NCM 30039034 (Ácido o-acetilsalicílico; o-acetilsalicilato de alumínio; salicilato de metila; diclorvós).

Fonte: SI5 Global · código registrado em Brasil · atualizado em 01/10/2026

Preço base (referência): R$ 9,99 — coletado em extrafarma.com.br em 01/10/2026, pode não estar atualizado

Código de barras

7896422501651

Código registrado em Brasil · prefixo 789

Classificação fiscal

NCM: 30039034Ácido o-acetilsalicílico; o-acetilsalicilato de alumínio; salicilato de metila; diclorvós

Descrição do produto

O que é Tadalafila 5mg 30 Comprimidos Revestidos Genérico Medley?

O Tadalafila 5mg 30 Comprimidos Revestidos Genérico Medley é um medicamento de uso diário indicado para homens adultos no tratamento da disfunção erétil (dificuldade de obter e/ou manter a ereção) e também para o tratamento dos sinais e sintomas da hiperplasia prostática benigna (HPB), que é o aumento benigno da próstata. Sua ação consiste em aumentar o fluxo sanguíneo no pênis, auxiliando na obtenção de uma ereção satisfatória para a atividade sexual, mediante estímulo. Além disso, relaxa a musculatura da próstata e da bexiga, aliviando os sintomas da HPB.

Conteúdo da embalagem: 30 comprimidos revestidos

Fabricado por: Medley

Indicação etária: Adulto

Composição Tadalafila 5mg 30 Comprimidos Revestidos Genérico Medley:

Princípio ativo: tadalafila 5mg

Excipientes: celulose microcristalina, lactose monoidratada, hiprolose, croscarmelose sódica, laurilsulfato de sódio, estearato de magnésio, hipromelose, dióxido de titânio, macrogol, óxido de ferro amarelo.

Para que serve Tadalafila?

A Tadalafila 5mg é um medicamento versátil, indicado para o tratamento de duas condições comuns em homens adultos. Ele atua relaxando os músculos e aumentando o fluxo de sangue em áreas específicas do corpo.

Tratamento da Disfunção Erétil (DE): Ajuda homens com dificuldade de obter ou manter uma ereção a alcançar um desempenho sexual satisfatório, desde que haja estímulo sexual.
Tratamento da Hiperplasia Prostática Benigna (HPB): Alivia os sinais e sintomas associados ao aumento da próstata, como dificuldade em urinar, jato urinário fraco e necessidade de urinar com frequência, inclusive durante a noite.

Como devo tomar Tadalafila 5mg?

O medicamento deve ser administrado por via oral, com um copo de água, e o comprimido deve ser engolido inteiro. Siga sempre a orientação do seu médico.

Uso: A dose recomendada é de 1 comprimido de 5mg por dia, administrado aproximadamente no mesmo horário.
Independente das refeições: O Tadalafila pode ser tomado com ou sem alimentos.
Não parta o comprimido: O medicamento não deve ser partido, aberto ou mastigado.
Duração do tratamento: A duração do tratamento será definida a critério médico.

Quando não devo tomar Tadalafila?

Este medicamento possui algumas contraindicações importantes. Não utilize Tadalafila nas seguintes situações:

Se você não apresenta disfunção erétil ou sinais e sintomas de Hiperplasia Prostática Benigna (HPB).
Se você tem alergia (hipersensibilidade) à tadalafila ou a qualquer outro componente da fórmula.
Se você está utilizando medicamentos que contenham nitratos, como propatilnitrato, isossorbida, nitroglicerina e dinitrato de isossorbitol, pois a combinação pode causar uma queda perigosa na pressão arterial.

Ficha técnica

Medicamento: True
MarcaPropria: Não
NumeroRegistroMS: 1.8326.0202.005-5
DescricaoBula: %0A%3Ch2%3ELaborat%26%23xF3%3Brio%3C%2Fh2%3E%0A%3Cp%3EEurofarma%3C%2Fp%3E%0A%3Ch2%3E%20Apresenta%26%23xE7%3B%26%23xE3%3Bo%20Tadalafila%20%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20Embalagem%20com%2030%20comprimidos%20contendo%205%20mg%20de%20tadalafila.%20%20%3Cbr%3E%20%3Cbr%3E%20EXCLUSIVAMENTE%20PARA%20ADMINISTRA%26%23xC7%3B%26%23xC3%3BO%20ORAL%20%20%3Cbr%3E%20USO%20ADULTO%20ACIMA%20DE%2018%20ANOS%20%20%3Cbr%3E%20%3Cbr%3E%20COMPOSI%26%23xC7%3B%26%23xC3%3BO%20%20%3Cbr%3E%20Cada%20comprimido%20cont%26%23xE9%3Bm%3A%20%20%3Cbr%3E%20tadalafila%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..5%20mg%3Cbr%3E%20Excipientes%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B.1%20comprimido%3Cbr%3E%20Excipientes%3A%20lactose%2C%20lactose%20monoidratada%2C%20hiprolose%2C%20laurilsulfato%20de%20s%26%23xF3%3Bdio%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20celulose%20microcristalina%2C%20di%26%23xF3%3Bxido%20de%20sil%26%23xED%3Bcio%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20hipromelose%2C%20triacetina%2C%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio.%3Cbr%3E%20_______________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20Embalagem%20com%202%20comprimidos%20contendo%2020%20mg%20de%20tadalafila.%20%20%3Cbr%3E%20%3Cbr%3E%20EXCLUSIVAMENTE%20PARA%20ADMINISTRA%26%23xC7%3B%26%23xC3%3BO%20ORAL%20%20%3Cbr%3E%20USO%20ADULTO%20ACIMA%20DE%2018%20ANOS%20%3Cbr%3E%20%20%3Cbr%3E%20COMPOSI%26%23xC7%3B%26%23xC3%3BO%20%20%3Cbr%3E%20Cada%20comprimido%20cont%26%23xE9%3Bm%3A%20%20%3Cbr%3E%20tadalafila%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..20%20mg%3Cbr%3E%20excipientes%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B1%20comprimido%3Cbr%3E%20Excipientes%3A%20lactose%2C%20lactose%20monoidratada%2C%20hiprolose%2C%20laurilsulfato%20de%20s%26%23xF3%3Bdio%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20celulose%20microcristalina%2C%20di%26%23xF3%3Bxido%20de%20sil%26%23xED%3Bcio%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20hipromelose%2C%20triacetina%2C%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3E%20Tadalafila%20%26%23x2013%3B%20Indica%26%23xE7%3B%26%23xF5%3Bes%20%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20A%20tadalafila%20%26%23xE9%3B%20indicada%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20A%20tadalafila%20%26%23xE9%3B%20indicada%20para%20o%20tratamento%20dos%20sinais%20e%20sintomas%20da%20hiperplasia%20prost%26%23xE1%3Btica%20benigna%20(HPB)%20em%20homens%20adultos%20incluindo%20aqueles%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20______________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20A%20tadalafila%20%26%23xE9%3B%20indicada%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3C%2Fp%3E%0A%3Ch2%3E%20Contra%20indica%26%23xE7%3B%26%23xF5%3Bes%20de%20Tadalafila%20%3C%2Fh2%3E%0A%3Cp%3EEm%20estudos%20cl%26%23xED%3Bnicos%2C%20a%20tadalafila%20mostrou%20aumentar%20os%20efeitos%20hipotensivos%20dos%20nitratos.%20Sup%26%23xF5%3Be-se%20que%20isto%20seja%20resultado%20dos%20efeitos%20combinados%20dos%20nitratos%20e%20tadalafila%20na%20via%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2FGMPc.%20Portanto%2C%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20a%20pacientes%20que%20est%26%23xE3%3Bo%20usando%20qualquer%20forma%20de%20nitrato%20org%26%23xE2%3Bnico%20%26%23xE9%3B%20contraindicada.%20A%20tadalafila%20n%26%23xE3%3Bo%20deve%20ser%20usada%20em%20pacientes%20com%20conhecida%20hipersensibilidade%20%26%23xE0%3B%20tadalafila%20ou%20a%20qualquer%20componente%20do%20comprimido.%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20homens%20que%20n%26%23xE3%3Bo%20apresentam%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%2Fou%20sinais%20e%20sintomas%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB).%3Cbr%3E%3C%2Fp%3E%0A%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%3C%2Famp-ad%3E%0A%3Ch2%3EAdvert%26%23xEA%3Bncias%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20A%20avalia%26%23xE7%3B%26%23xE3%3Bo%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20deve%20incluir%20a%20determina%26%23xE7%3B%26%23xE3%3Bo%20de%20suas%20causas%20potenciais%20e%20a%20identifica%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20apropriado%20ap%26%23xF3%3Bs%20uma%20avalia%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20adequada.%3Cbr%3E%20A%20seguran%26%23xE7%3Ba%20e%20a%20efic%26%23xE1%3Bcia%20das%20combina%26%23xE7%3B%26%23xF5%3Bes%20de%20tadalafila%20e%20outros%20inibidores%20da%20PDE5%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20n%26%23xE3%3Bo%20foram%20estudadas.%20Portanto%2C%20o%20uso%20de%20tais%20combina%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendado.%3Cbr%3E%20Priapismo%20foi%20relatado%20com%20os%20inibidores%20da%20PDE5%2C%20incluindo%20tadalafila.%20Pacientes%20que%20apresentem%20ere%26%23xE7%3B%26%23xF5%3Bes%20com%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%204%20horas%20ou%20mais%20devem%20ser%20instru%26%23xED%3Bdos%20para%20procurarem%20assist%26%23xEA%3Bncia%20m%26%23xE9%3Bdica%20imediata.%20Se%20o%20priapismo%20n%26%23xE3%3Bo%20for%20tratado%20imediatamente%2C%20pode%20resultar%20em%20les%26%23xE3%3Bo%20do%20tecido%20peniano%20e%20perda%20permanente%20da%20pot%26%23xEA%3Bncia.%3Cbr%3E%20Tadalafila%20deve%20ser%20usada%20com%20cautela%20em%20pacientes%20que%20t%26%23xEA%3Bm%20condi%26%23xE7%3B%26%23xF5%3Bes%20que%20possam%20predisp%26%23xF4%3B-los%20ao%20priapismo%20(tais%20como%20anemia%20falciforme%2C%20mieloma%20m%26%23xFA%3Bltiplo%20ou%20leucemia)%2C%20ou%20em%20pacientes%20com%20deforma%26%23xE7%3B%26%23xE3%3Bo%20anat%26%23xF4%3Bmica%20do%20p%26%23xEA%3Bnis%20(tais%20como%20angula%26%23xE7%3B%26%23xE3%3Bo%2C%20fibrose%20cavernosa%20ou%20doen%26%23xE7%3Ba%20de%20Peyronie).%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20recomendar%20aos%20pacientes%20que%20interrompam%20o%20uso%20de%20inibidores%20de%20PDE5%2C%20incluindo%20tadalafila%2C%20bem%20como%20a%20procurarem%20uma%20orienta%26%23xE7%3B%26%23xE3%3Bo%20especializada%20em%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20Estes%20eventos%2C%20que%20podem%20estar%20acompanhados%20de%20zumbido%20e%20vertigem%2C%20foram%20relatados%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20%26%23xE0%3B%20introdu%26%23xE7%3B%26%23xE3%3Bo%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20de%20inibidores%20PDE5%20ou%20a%20outros%20fatores.%3Cbr%3E%20Pacientes%20com%20suspeita%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%20devem%20ser%20examinados%20para%20descartar%20a%20presen%26%23xE7%3Ba%20de%20carcinoma%20prost%26%23xE1%3Btico.%3Cbr%3E%20Tadalafila%20deve%20ser%20usada%20com%20cautela%20quando%20prescrita%20para%20pacientes%20que%20tomam%20alfabloqueadores%2C%20como%20a%20doxazosina%2C%20pois%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20pode%20levar%20a%20uma%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica%20em%20alguns%20pacientes.%20Em%20um%20estudo%20com%20homens%20sadios%2C%20tadalafila%20foi%20administrada%20com%20doxazosina%208%20mg%20e%20houve%20um%20aumento%20do%20efeito%20hipotensor%20da%20doxazosina.%20Doses%20menores%20de%20doxazosina%20n%26%23xE3%3Bo%20foram%20testadas.%20Quando%20tadalafila%20%26%23xE9%3B%20administrada%20concomitantemente%20com%20um%20alfa-bloqueador%2C%20os%20pacientes%20devem%20estar%20est%26%23xE1%3Bveis%20com%20a%20terapia%20com%20alfabloqueadores%20antes%20de%20iniciar%20o%20tratamento%20com%20tadalafila%20(ver%20INTERA%26%23xC7%3B%26%23xD5%3BES%20MEDICAMENTOSAS).%3Cbr%3E%20Assim%20como%20outros%20inibidores%20da%20PDE5%2C%20tadalafila%20tem%20propriedades%20vasodilatadoras%20sist%26%23xEA%3Bmicas%20que%20podem%20resultar%20em%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20transit%26%23xF3%3Bria%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea.%20Antes%20de%20prescrever%20tadalafila%2C%20os%20m%26%23xE9%3Bdicos%20devem%20considerar%20cuidadosamente%20se%20seus%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente%20podem%20ser%20afetados%20desfavoravelmente%20por%20tais%20efeitos%20vasodilatadores.%3Cbr%3E%20%3Cbr%3E%20Carcinog%26%23xEA%3Bnese%2C%20Mutag%26%23xEA%3Bnese%2C%20Danos%20%26%23xE0%3B%20Fertilidade%3A%20tadalafila%20n%26%23xE3%3Bo%20foi%20carcinog%26%23xEA%3Bnica%20em%20ratos%20ou%20camundongos%20quando%20administrada%20por%2024%20meses.%3Cbr%3E%20Tadalafila%20n%26%23xE3%3Bo%20foi%20mutag%26%23xEA%3Bnica%20ou%20genot%26%23xF3%3Bxica%20em%20ensaios%20bacterianos%20in%20vitro%20e%20com%20c%26%23xE9%3Blulas%20de%20mam%26%23xED%3Bferos%2C%20e%20em%20linf%26%23xF3%3Bcitos%20humanos%20in%20vitro%20e%20ensaios%20com%20micron%26%23xFA%3Bcleo%20de%20rato%20in%20vivo.%3Cbr%3E%20N%26%23xE3%3Bo%20houve%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20fertilidade%20em%20ratos%20machos%20e%20f%26%23xEA%3Bmeas%20em%20doses%20at%26%23xE9%3B%20400%20mg%2FKg%20por%202%20anos.%20Em%20c%26%23xE3%3Bes%20recebendo%20tadalafila%20diariamente%20por%206%20a%2012%20meses%20em%20doses%20de%2025%20mg%2FKg%2Fdia%20e%20acima%2C%20houve%20altera%26%23xE7%3B%26%23xF5%3Bes%20no%20epit%26%23xE9%3Blio%20do%20t%26%23xFA%3Bbulo%20semin%26%23xED%3Bfero%20que%20resultaram%20numa%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20espermatog%26%23xEA%3Bnese%20em%20alguns%20c%26%23xE3%3Bes.%3Cbr%3E%20%3Cbr%3E%20Gravidez%20(Categoria%20B)%3A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20uso%20em%20mulheres.%20N%26%23xE3%3Bo%20houve%20evid%26%23xEA%3Bncia%20de%20teratogenicidade%2C%20embriotoxicidade%20ou%20fetotoxicidade%20em%20ratos%20e%20camundongos%20que%20receberam%20at%26%23xE9%3B%201.000%20mg%2FKg%2Fdia.%20Em%20um%20estudo%20de%20desenvolvimento%20pr%26%23xE9%3B%20e%20p%26%23xF3%3Bs-natal%20em%20ratos%2C%20a%20dose%20de%20efeito%20n%26%23xE3%3Bo%20observado%20foi%20de%2030%20mg%2FKg%2Fdia.%20Na%20rata%20prenha%2C%20a%20AUC%20para%20droga%20livre%20calculada%20nessa%20dose%20foi%20aproximadamente%2018%20ou%206%20vezes%20a%20AUC%20humana%20em%20uma%20dose%20de%2020%20ou%2040%20mg.%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20estudos%20de%20tadalafila%20em%20mulheres%20gr%26%23xE1%3Bvidas.%3Cbr%3E%20%3Cbr%3E%20Efeito%20sobre%20a%20Capacidade%20de%20Dirigir%20e%20Operar%20M%26%23xE1%3Bquinas%3A%20nenhum%20relato.%3Cbr%3E%20%3Cbr%3E%20Uso%20Pedi%26%23xE1%3Btrico%3A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20o%20uso%20em%20rec%26%23xE9%3Bm-nascidos%20e%20crian%26%23xE7%3Bas.%3Cbr%3E%20%3Cbr%3E%20Uso%20Geri%26%23xE1%3Btrico%3A%20indiv%26%23xED%3Bduos%20idosos%20sadios%20(65%20anos%20ou%20mais)%20tiveram%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20do%20clearance%20de%20tadalafila%2C%20resultando%20em%20uma%20alta%20de%2025%25%20de%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20droga%20(AUC)%2C%20quando%20comparados%20a%20indiv%26%23xED%3Bduos%20saud%26%23xE1%3Bveis%2C%20de%20idades%20entre%2019%20e%2045%20anos.%20Este%20efeito%20da%20idade%20n%26%23xE3%3Bo%20%26%23xE9%3B%20clinicamente%20significativo%20e%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20da%20dose.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Doen%26%23xE7%3Ba%20Cardiovascular%3A%20a%20atividade%20sexual%20possui%20um%20risco%20card%26%23xED%3Baco%20potencial%20para%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente.%20Portanto%2C%20tratamentos%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20incluindo%20tadalafila%2C%20n%26%23xE3%3Bo%20devem%20ser%20usados%20em%20homens%20com%20doen%26%23xE7%3Ba%20card%26%23xED%3Baca%2C%20para%20os%20quais%20a%20atividade%20sexual%20%26%23xE9%3B%20desaconselh%26%23xE1%3Bvel.%20Os%20seguintes%20grupos%20de%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20n%26%23xE3%3Bo%20foram%20inclu%26%23xED%3Bdos%20nos%20estudos%20cl%26%23xED%3Bnicos%3A%3Cbr%3E%20-Pacientes%20com%20infarto%20do%20mioc%26%23xE1%3Brdio%20nos%20%26%23xFA%3Bltimos%2090%20dias%3B%3Cbr%3E%20-Pacientes%20com%20angina%20inst%26%23xE1%3Bvel%20ou%20angina%20ocorrida%20durante%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%3B%3Cbr%3E%20-Pacientes%20com%20insufici%26%23xEA%3Bncia%20card%26%23xED%3Baca%20classe%202%20ou%20maior%20da%20%26%23x93%3BNew%20York%20Heart%20Association%26%23x94%3B%20nos%20%26%23xFA%3Bltimos%206%20meses%3B%3Cbr%3E%20-Pacientes%20com%20arritmias%20n%26%23xE3%3Bo%20controladas%2C%20hipotens%26%23xE3%3Bo%20(%26lt%3B%2090%2F50%20mmHg)%2C%20ou%20hipertens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20controlada%20e%3Cbr%3E%20-Pacientes%20com%20acidente%20vascular%20cerebral%20nos%20%26%23xFA%3Bltimos%206%20meses.%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20considerar%20o%20risco%20card%26%23xED%3Baco%20potencial%20da%20atividade%20sexual%20em%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente.%20Pacientes%20que%20apresentem%20sintomas%20durante%20a%20atividade%20sexual%20devem%20ser%20aconselhados%20a%20absterem-se%20de%20novas%20atividades%20sexuais%20e%20relatarem%20o%20epis%26%23xF3%3Bdio%20ao%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Insufici%26%23xEA%3Bncia%20Hep%26%23xE1%3Btica%3A%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%20(Child-Pugh%20Classes%20A%20e%20B)%20%26%23xE9%3B%20compar%26%23xE1%3Bvel%20%26%23xE0%3B%20exposi%26%23xE7%3B%26%23xE3%3Bo%20em%20indiv%26%23xED%3Bduos%20sadios.%20N%26%23xE3%3Bo%20existem%20dados%20dispon%26%23xED%3Bveis%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(Child-Pugh%20Classe%20C).%20Portanto%2C%20tadalafila%20deve%20ser%20usada%20com%20cautela%20quando%20prescrita%20para%20pacientes%20deste%20grupo.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20uma%20vez%20ao%20dia%20n%26%23xE3%3Bo%20foi%20extensivamente%20avaliada%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica.%20Se%20tadalafila%20for%20prescrita%2C%20o%20m%26%23xE9%3Bdico%20prescritor%20dever%26%23xE1%3B%20avaliar%20cuidadosamente%20a%20rela%26%23xE7%3B%26%23xE3%3Bo%20risco-benef%26%23xED%3Bcio%20individualmente.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Insufici%26%23xEA%3Bncia%20Renal%3A%20devido%20ao%20aumento%20da%20exposi%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%20(AUC)%2C%20da%20experi%26%23xEA%3Bncia%20cl%26%23xED%3Bnica%20limitada%20e%20pela%20pouca%20influ%26%23xEA%3Bncia%20do%20clearance%20na%20di%26%23xE1%3Blise%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendada%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20uma%20vez%20ao%20dia%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20grave.%3Cbr%3E%20%3Cbr%3E%20Combina%26%23xE7%3B%26%23xE3%3Bo%20com%20outras%20Terapias%20para%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20a%20seguran%26%23xE7%3Ba%20e%20efic%26%23xE1%3Bcia%20de%20combina%26%23xE7%3B%26%23xF5%3Bes%20de%20tadalafila%20e%20outros%20inibidores%20da%20PDE5%20ou%20tratamentos%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20n%26%23xE3%3Bo%20foram%20estudadas.%20Portanto%2C%20o%20uso%20de%20tais%20combina%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendado.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%20Portanto%2C%20deve%20ser%20usado%20com%20cautela%20em%20pacientes%20que%20apresentem%20intoler%26%23xE2%3Bncia%20%26%23xE0%3B%20lactose.%3Cbr%3E%20A%20efic%26%23xE1%3Bcia%20deste%20medicamento%20depende%20da%20capacidade%20funcional%20do%20paciente.%3Cbr%3E%20_______________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20A%20avalia%26%23xE7%3B%26%23xE3%3Bo%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20deve%20incluir%20a%20determina%26%23xE7%3B%26%23xE3%3Bo%20de%20suas%20causas%20potenciais%20e%20a%20identifica%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20apropriado%20ap%26%23xF3%3Bs%20uma%20avalia%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20adequada.%3Cbr%3E%20Priapismo%20foi%20relatado%20raramente%20com%20os%20inibidores%20da%20PDE5%2C%20incluindo%20a%20tadalafila.%20Pacientes%20que%20apresentem%20ere%26%23xE7%3B%26%23xF5%3Bes%20com%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%204%20horas%20ou%20mais%20devem%20ser%20instru%26%23xED%3Bdos%20para%20procurarem%20assist%26%23xEA%3Bncia%20m%26%23xE9%3Bdica%20imediata.%20Se%20o%20priapismo%20n%26%23xE3%3Bo%20for%20tratado%20imediatamente%2C%20pode%20resultar%20em%20les%26%23xE3%3Bo%20do%20tecido%20peniano%20e%20perda%20permanente%20da%20pot%26%23xEA%3Bncia.%3Cbr%3E%20Tadalafila%20deve%20ser%20usada%20com%20cautela%20em%20pacientes%20que%20t%26%23xEA%3Bm%20condi%26%23xE7%3B%26%23xF5%3Bes%20que%20possam%20predisp%26%23xF4%3B-los%20ao%20priapismo%20(tais%20como%20anemia%20falciforme%2C%20mieloma%20m%26%23xFA%3Bltiplo%20ou%20leucemia)%2C%20ou%20em%20pacientes%20com%20deforma%26%23xE7%3B%26%23xE3%3Bo%20anat%26%23xF4%3Bmica%20do%20p%26%23xEA%3Bnis%20(tais%20como%20angula%26%23xE7%3B%26%23xE3%3Bo%2C%20fibrose%20cavernosa%20ou%20doen%26%23xE7%3Ba%20de%20Peyronie).%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20recomendar%20aos%20pacientes%20que%20interrompam%20o%20uso%20de%20inibidores%20de%20PDE5%2C%20incluindo%20tadalafila%2C%20bem%20como%20a%20procurarem%20uma%20orienta%26%23xE7%3B%26%23xE3%3Bo%20especializada%20em%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20Estes%20eventos%2C%20que%20podem%20estar%20acompanhados%20de%20zumbido%20e%20vertigem%2C%20foram%20relatados%20na%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20%26%23xE0%3B%20introdu%26%23xE7%3B%26%23xE3%3Bo%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20de%20inibidores%20PDE5%20ou%20a%20outros%20fatores.%3Cbr%3E%20Tadalafila%20deve%20ser%20usada%20com%20cautela%20quando%20prescrita%20para%20pacientes%20que%20tomam%20alfabloqueadores%2C%20como%20a%20doxazosina%2C%20pois%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20pode%20levar%20a%20uma%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica%20em%20alguns%20pacientes.%20Em%20um%20estudo%20com%20homens%20sadios%2C%20tadalafila%20foi%20administrada%20com%20doxazosina%208%20mg%20e%20houve%20um%20aumento%20do%20efeito%20hipotensor%20da%20doxazosina.%20Doses%20menores%20de%20doxazosina%20n%26%23xE3%3Bo%20foram%20testadas.%20Quando%20tadalafila%20%26%23xE9%3B%20administrada%20concomitantemente%20com%20um%20alfa-bloqueador%2C%20os%20pacientes%20devem%20estar%20est%26%23xE1%3Bveis%20com%20a%20terapia%20com%20alfa-%20bloqueadores%20antes%20de%20iniciar%20o%20tratamento%20com%20tadalafila.%20Em%20um%20estudo%20de%20farmacologia%20cl%26%23xED%3Bnica%20com%2018%20volunt%26%23xE1%3Brios%20sadios%20que%20receberam%20uma%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%2C%20n%26%23xE3%3Bo%20foi%20observada%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica%20com%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20de%20tansulosina%2C%20um%20alfa%20bloqueador%20(ver%20INTERA%26%23xC7%3B%26%23xD5%3BES%20MEDICAMENTOSAS).%3Cbr%3E%20Assim%20como%20outros%20inibidores%20da%20PDE5%2C%20tadalafila%20tem%20propriedades%20vasodilatadoras%20sist%26%23xEA%3Bmicas%20que%20podem%20resultar%20em%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20transit%26%23xF3%3Bria%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea.%20Antes%20de%20prescrever%20tadalafila%2C%20os%20m%26%23xE9%3Bdicos%20devem%20considerar%20cuidadosamente%20se%20seus%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente%20podem%20ser%20afetados%20desfavoravelmente%20por%20tais%20efeitos%20vasodilatadores.%3Cbr%3E%20%3Cbr%3E%20Carcinog%26%23xEA%3Bnese%2C%20mutag%26%23xEA%3Bnese%2C%20danos%20%26%23xE0%3B%20fertilidade%3A%20tadalafila%20n%26%23xE3%3Bo%20foi%20carcinog%26%23xEA%3Bnica%20em%20ratos%20ou%20camundongos%20quando%20administrada%20por%2024%20meses.%3Cbr%3E%20Tadalafila%20n%26%23xE3%3Bo%20foi%20mutag%26%23xEA%3Bnica%20ou%20genot%26%23xF3%3Bxica%20em%20ensaios%20bacterianos%20in%20vitro%20e%20com%20c%26%23xE9%3Blulas%20de%20mam%26%23xED%3Bferos%2C%20e%20em%20linf%26%23xF3%3Bcitos%20humanos%20in%20vitro%20e%20ensaios%20com%20micron%26%23xFA%3Bcleo%20de%20rato%20in%20vivo.%3Cbr%3E%20N%26%23xE3%3Bo%20houve%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20fertilidade%20em%20ratos%20machos%20e%20f%26%23xEA%3Bmeas%20em%20doses%20at%26%23xE9%3B%20400%20mg%2Fkg%20por%202%20anos.%20Em%20c%26%23xE3%3Bes%20recebendo%20tadalafila%20diariamente%20por%206%20a%2012%20meses%20em%20doses%20de%2025%20mg%2Fkg%2Fdia%20e%20acima%2C%20houve%20altera%26%23xE7%3B%26%23xF5%3Bes%20no%20epit%26%23xE9%3Blio%20do%20t%26%23xFA%3Bbulo%20semin%26%23xED%3Bfero%20que%20resultaram%20numa%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20espermatog%26%23xEA%3Bnese%20em%20alguns%20c%26%23xE3%3Bes.%3Cbr%3E%20%3Cbr%3E%20Gravidez%20(Categoria%20B)%3A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20uso%20em%20mulheres.%20N%26%23xE3%3Bo%20houve%20evid%26%23xEA%3Bncia%20de%20teratogenicidade%2C%20embriotoxicidade%20ou%20fetotoxicidade%20em%20ratos%20e%20camundongos%20que%20receberam%20at%26%23xE9%3B%201.000%20mg%2FKg%2Fdia.%20Em%20um%20estudo%20de%20desenvolvimento%20pr%26%23xE9%3B%20e%20p%26%23xF3%3Bs-%20natal%20em%20ratos%2C%20a%20dose%20de%20efeito%20n%26%23xE3%3Bo%20observado%20foi%20de%2030%20mg%2FKg%2Fdia.%20Na%20rata%20prenha%2C%20a%20AUC%20para%20droga%20livre%20calculada%20nessa%20dose%20foi%20aproximadamente%2018%20ou%206%20vezes%20a%20AUC%20humana%20numa%20dose%20de%2020%20ou%2040mg.%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20estudos%20de%20tadalafila%20em%20mulheres%20gr%26%23xE1%3Bvidas.%3Cbr%3E%20%3Cbr%3E%20Efeito%20Sobre%20a%20Capacidade%20de%20Dirigir%20e%20Operar%20M%26%23xE1%3Bquinas%3A%20nenhum%20relato.%3Cbr%3E%20%3Cbr%3E%20Uso%20Pedi%26%23xE1%3Btrico%3A%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicado%20para%20o%20uso%20em%20rec%26%23xE9%3Bm-nascidos%20e%20crian%26%23xE7%3Bas.%3Cbr%3E%20%3Cbr%3E%20Uso%20Geri%26%23xE1%3Btrico%3A%20indiv%26%23xED%3Bduos%20idosos%20sadios%20(65%20anos%20ou%20mais)%20tiveram%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20do%20clearance%20de%20tadalafila%2C%20resultando%20em%20uma%20alta%20de%2025%25%20de%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20droga%20(AUC)%2C%20quando%20comparados%20a%20indiv%26%23xED%3Bduos%20saud%26%23xE1%3Bveis%2C%20de%20idades%20entre%2019%20e%2045%20anos.%20Este%20efeito%20da%20idade%20n%26%23xE3%3Bo%20%26%23xE9%3B%20clinicamente%20significativo%20e%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20da%20dose.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Doen%26%23xE7%3Ba%20Cardiovascular%3A%20a%20atividade%20sexual%20possui%20um%20risco%20card%26%23xED%3Baco%20potencial%20para%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente.%20Portanto%2C%20tratamentos%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20incluindo%20tadalafila%2C%20n%26%23xE3%3Bo%20devem%20ser%20usados%20em%20homens%20com%20doen%26%23xE7%3Ba%20card%26%23xED%3Baca%2C%20para%20os%20quais%20a%20atividade%20sexual%20%26%23xE9%3B%20desaconselh%26%23xE1%3Bvel.%20Os%20seguintes%20grupos%20de%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20n%26%23xE3%3Bo%20foram%20inclu%26%23xED%3Bdos%20nos%20estudos%20cl%26%23xED%3Bnicos%3A%3Cbr%3E%20-pacientes%20com%20infarto%20do%20mioc%26%23xE1%3Brdio%20nos%20%26%23xFA%3Bltimos%2090%20dias%3B%3Cbr%3E%20-pacientes%20com%20angina%20inst%26%23xE1%3Bvel%20ou%20angina%20ocorrida%20durante%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%3B%3Cbr%3E%20-pacientes%20com%20insufici%26%23xEA%3Bncia%20card%26%23xED%3Baca%20classe%202%20ou%20maior%20da%20%26%23x93%3BNew%20York%20Heart%20Association%26%23x94%3B%20nos%20%26%23xFA%3Bltimos%206%20meses%3B%3Cbr%3E%20-pacientes%20com%20arritmias%20n%26%23xE3%3Bo%20controladas%2C%20hipotens%26%23xE3%3Bo%20(%26lt%3B%2090%2F50%20mmHg)%2C%20ou%20hipertens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20controlada%20e%3Cbr%3E%20-pacientes%20com%20acidente%20vascular%20cerebral%20nos%20%26%23xFA%3Bltimos%206%20meses.%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20considerar%20o%20risco%20card%26%23xED%3Baco%20potencial%20da%20atividade%20sexual%20em%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20pr%26%23xE9%3B-existente.%20Pacientes%20que%20apresentem%20sintomas%20durante%20a%20atividade%20sexual%20devem%20ser%20aconselhados%20a%20absterem-se%20de%20novas%20atividades%20sexuais%20e%20relatarem%20o%20epis%26%23xF3%3Bdio%20ao%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Insufici%26%23xEA%3Bncia%20Hep%26%23xE1%3Btica%3A%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%20(Child-Pugh%20Classe%20A%20e%20B)%20%26%23xE9%3B%20compar%26%23xE1%3Bvel%20%26%23xE0%3B%20exposi%26%23xE7%3B%26%23xE3%3Bo%20em%20indiv%26%23xED%3Bduos%20sadios.%20N%26%23xE3%3Bo%20existem%20dados%20dispon%26%23xED%3Bveis%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(Child-Pugh%20Classe%20C).%20Portanto%2C%20tadalafila%20deve%20ser%20usada%20com%20cautela%20quando%20prescrito%20para%20pacientes%20deste%20grupo.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Insufici%26%23xEA%3Bncia%20Renal%3A%20em%20um%20estudo%20de%20farmacologia%20cl%26%23xED%3Bnica%2C%20usando%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20(5%20a%2010%20mg)%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20duplicou%20em%20pacientes%20com%20clearance%20de%20creatinina%2030%20a%2080%20mL%2Fmin.%20Em%20um%20estudo%20de%20farmacologia%20cl%26%23xED%3Bnica%20com%20dose%20de%2010%20mg%2C%20a%20dor%20lombar%20foi%20relatada%20como%20um%20evento%20adverso%20limitante%20em%20pacientes%20masculinos%20com%20clearance%20de%20creatinina%2030%20a%2050%20mL%2Fmin.%20Em%20uma%20dose%20de%205%20mg%2C%20a%20incid%26%23xEA%3Bncia%20e%20severidade%20de%20dor%20lombar%20n%26%23xE3%3Bo%20foi%20significativamente%20diferente%20que%20em%20indiv%26%23xED%3Bduos%20sadios.%20Pacientes%20em%20hemodi%26%23xE1%3Blises%20tomando%2010%20ou%2020%20mg%20de%20tadalafila%2C%20n%26%23xE3%3Bo%20relataram%20dor%20lombar.%20Em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20renal%2C%20incluindo%20aqueles%20em%20hemodi%26%23xE1%3Blise%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20foi%20maior%20que%20em%20indiv%26%23xED%3Bduos%20saud%26%23xE1%3Bveis.%3Cbr%3E%20%3Cbr%3E%20Combina%26%23xE7%3B%26%23xE3%3Bo%20com%20Outras%20Terapias%20para%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20a%20seguran%26%23xE7%3Ba%20e%20efic%26%23xE1%3Bcia%20de%20combina%26%23xE7%3B%26%23xF5%3Bes%20de%20tadalafila%20e%20outros%20inibidores%20da%20PDE5%20ou%20tratamentos%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20n%26%23xE3%3Bo%20foram%20estudadas.%20Portanto%2C%20o%20uso%20de%20tais%20combina%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendado.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%20Portanto%2C%20deve%20ser%20usado%20com%20cautela%20em%20pacientes%20que%20apresentem%20intoler%26%23xE2%3Bncia%20%26%23xE0%3B%20lactose.%3Cbr%3E%20A%20efic%26%23xE1%3Bcia%20deste%20medicamento%20depende%20da%20capacidade%20funcional%20do%20paciente.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EIntera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%20de%20Tadalafila%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20N%26%23xE3%3Bo%20%26%23xE9%3B%20esperado%20que%20a%20tadalafila%20cause%20inibi%26%23xE7%3B%26%23xE3%3Bo%20ou%20indu%26%23xE7%3B%26%23xE3%3Bo%20clinicamente%20significativa%20do%20clearance%20de%20drogas%20metabolizadas%20pelas%20isoformas%20do%20CYP450.%20Estudos%20confirmaram%20que%20a%20tadalafila%20n%26%23xE3%3Bo%20inibe%20ou%20induz%20as%20isoformas%20do%20CYP450%2C%20incluindo%20CYP1A2%2C%20CYP3A4%2C%20CYP2C9%2C%20CYP2C19%2C%20CYP2D6%20e%20CYP2E1.%3Cbr%3E%20%3Cbr%3E%20Cetoconazol%3A%20a%20tadalafila%20%26%23xE9%3B%20principalmente%20metabolizada%20pelo%20CYP3A4.%20Um%20inibidor%20seletivo%20do%20CYP3A4%2C%20cetoconazol%20(400%20mg%20diariamente)%2C%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20312%25%20e%20a%20Cm%26%23xE1%3Bx%20em%2022%25%2C%20e%20cetoconazol%20(200%20mg%20diariamente)%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20107%25%20e%20Cm%26%23xE1%3Bx%20em%2015%25%20com%20rela%26%23xE7%3B%26%23xE3%3Bo%20aos%20valores%20de%20AUC%20e%20Cm%26%23xE1%3Bx%20para%20tadalafila%20isoladamente.%3Cbr%3E%20Ritonavir%3A%20ritonavir%20(200%20mg%20duas%20vezes%20ao%20dia)%2C%20um%20inibidor%20do%20CYP3A4%2C%20CYP2C9%2C%20CYP2C19%20e%20CYP2D6%2C%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20124%25%20sem%20altera%26%23xE7%3B%26%23xE3%3Bo%20na%20Cm%26%23xE1%3Bx.%20Embora%20intera%26%23xE7%3B%26%23xF5%3Bes%20espec%26%23xED%3Bficas%20n%26%23xE3%3Bo%20tenham%20sido%20estudadas%2C%20outros%20inibidores%20de%20protease%20do%20HIV%2C%20como%20o%20saquinavir%20e%20outros%20inibidores%20da%20CYP3A4%2C%20tais%20como%20eritromicina%20e%20itraconazol%2C%20provavelmente%20tamb%26%23xE9%3Bm%20aumentariam%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Rifampicina%3A%20um%20indutor%20do%20CYP3A4%2C%20rifampicina%20(600%20mg%20diariamente)%2C%20reduziu%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%2088%25%20e%20Cm%26%23xE1%3Bx%20em%2046%25%2C%20com%20rela%26%23xE7%3B%26%23xE3%3Bo%20aos%20valores%20de%20AUC%20e%20Cm%26%23xE1%3Bx%20para%20tadalafila%20isolada.%20Pode-se%20esperar%20que%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20outros%20indutores%20CYP3A4%20tamb%26%23xE9%3Bm%20possa%20diminuir%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%20A%20redu%26%23xE7%3B%26%23xE3%3Bo%20da%20exposi%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20com%20a%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20de%20rifampicina%20pode%20ser%20antecipada%20e%20diminuir%20a%20efic%26%23xE1%3Bcia%20de%20tadalafila%20administrada%20uma%20vez%20ao%20dia.%20A%20magnitude%20da%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20efic%26%23xE1%3Bcia%20%26%23xE9%3B%20desconhecida.%20Pode-se%20esperar%20que%20com%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20outros%20indutores%20do%20CYP3A4%20tamb%26%23xE9%3Bm%20haver%26%23xE1%3B%20diminui%26%23xE7%3B%26%23xE3%3Bo%20nas%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Agentes%20Anti-hipertensivos%3A%20tadalafila%20tem%20propriedades%20vasodilatadoras%20sist%26%23xEA%3Bmicas%20e%20pode%20aumentar%20os%20efeitos%20hipotensores%20dos%20agentes%20anti-hipertensivos.%20Adicionalmente%2C%20em%20pacientes%20tomando%20m%26%23xFA%3Bltiplos%20agentes%20anti-%20hipertensivos%2C%20cuja%20hipertens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20bem%20controlada%2C%20foram%20observadas%20redu%26%23xE7%3B%26%23xF5%3Bes%20maiores%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea.%20Estas%20redu%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20foram%20associadas%20com%20sintomas%20hipotensivos%20na%20grande%20maioria%20dos%20pacientes.%20Um%20apropriado%20aconselhamento%20m%26%23xE9%3Bdico%20deve%20ser%20dado%20aos%20pacientes%20quando%20estes%20s%26%23xE3%3Bo%20tratados%20com%20medicamentos%20anti-hipertensivos%20e%20tadalafila.%20Em%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%2C%20o%20potencial%20para%20a%20tadalafila%20aumentar%20os%20efeitos%20hipotensivos%20dos%20agentes%20anti-hipertensivos%20foi%20examinado.%20As%20classes%20principais%20de%20agentes%20anti-hipertensivos%20foram%20estudadas%2C%20incluindo%20bloqueadores%20de%20canais%20de%20c%26%23xE1%3Blcio%20(amlodipina)%2C%20inibidores%20da%20enzima%20conversora%20de%20angiotensina%20(ECA)%20(enalapril)%2C%20bloqueadores%20do%20receptor%20beta-adren%26%23xE9%3Brgico%20(metoprolol)%2C%20diur%26%23xE9%3Bticos%20tiaz%26%23xED%3Bdicos%20(bendrofluazida)%20e%20bloqueadores%20do%20receptor%20de%20angiotensina%20II%20(v%26%23xE1%3Brios%20tipos%20e%20doses%2C%20sozinhos%20ou%20em%20combina%26%23xE7%3B%26%23xE3%3Bo%20com%20tiazidas%2C%20bloqueadores%20de%20canal%20de%20c%26%23xE1%3Blcio%2C%20betabloqueadores%20e%2Fou%20alfabloqueadores).%20Tadalafila%20n%26%23xE3%3Bo%20tem%20intera%26%23xE7%3B%26%23xE3%3Bo%20clinicamente%20significativa%20com%20nenhuma%20dessas%20classes.%20A%20an%26%23xE1%3Blise%20dos%20estudos%20cl%26%23xED%3Bnicos%20fase%203%20tamb%26%23xE9%3Bm%20n%26%23xE3%3Bo%20mostrou%20diferen%26%23xE7%3Bas%20nos%20eventos%20adversos%20em%20pacientes%20tomando%20tadalafila%20com%20ou%20sem%20medica%26%23xE7%3B%26%23xE3%3Bo%20anti-hipertensiva.%3Cbr%3E%20%3Cbr%3E%20Agentes%20Bloqueadores%20Alfa-adren%26%23xE9%3Brgicos%3A%20em%20dois%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%20nenhuma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20foi%20observada%20quando%20a%20tadalafila%20foi%20coadministrada%20em%20indiv%26%23xED%3Bduos%20tomando%20tansulosina%2C%20um%20bloqueador%20seletivo%20alfa-adren%26%23xE9%3Brgico.%20Quando%20tadalafila%20foi%20coadministrada%20em%20indiv%26%23xED%3Bduos%20sadios%20tomando%20doxazosina%20(4-8%20mg%20diariamente)%2C%20um%20bloqueador%20alfa-adren%26%23xE9%3Brgico%2C%20houve%20um%20aumento%20dos%20efeitos%20hipotensores%20da%20doxazosina.%20O%20n%26%23xFA%3Bmero%20de%20indiv%26%23xED%3Bduos%20com%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20em%20p%26%23xE9%3B%2C%20potencialmente%20clinicamente%20significativa%2C%20foi%20maior%20para%20esta%20combina%26%23xE7%3B%26%23xE3%3Bo.%20Nestes%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%20houve%20sintomas%20associados%20com%20a%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20incluindo%20s%26%23xED%3Bncope.%20Quando%20tadalafila%20%26%23xE9%3B%20administrada%20concomitantemente%20com%20um%20alfa-bloqueador%2C%20os%20pacientes%20devem%20estar%20est%26%23xE1%3Bveis%20com%20a%20terapia%20com%20alfa-bloqueador%20antes%20de%20iniciar%20o%20tratamento%20com%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20%26%23xC1%3Blcool%3A%20tadalafila%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20alco%26%23xF3%3Blicas%20e%20o%20%26%23xE1%3Blcool%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%20Em%20altas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C7%20g%2FKg)%2C%20a%20adi%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20n%26%23xE3%3Bo%20induziu%20diminui%26%23xE7%3B%26%23xE3%3Bo%20estatisticamente%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20m%26%23xE9%3Bdia.%20Em%20alguns%20indiv%26%23xED%3Bduos%2C%20foram%20observadas%20tontura%20postural%20e%20hipotens%26%23xE3%3Bo%20ortost%26%23xE1%3Btica.%20Quando%20tadalafila%20foi%20administrada%20com%20baixas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C6%20g%2FKg)%2C%20hipotens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20observada%20e%20tonturas%20ocorreram%20com%20frequ%26%23xEA%3Bncia%20similar%20ao%20%26%23xE1%3Blcool%20administrado%20isoladamente.%3Cbr%3E%20%3Cbr%3E%20Antagonistas%20H2%3A%20Um%20aumento%20no%20pH%20g%26%23xE1%3Bstrico%20resultante%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nizatidina%20n%26%23xE3%3Bo%20teve%20efeito%20significativo%20na%20farmacocin%26%23xE9%3Btica%20de%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Anti%26%23xE1%3Bcidos%20(Hidr%26%23xF3%3Bxido%20de%20Magn%26%23xE9%3Bsio%2F%20Hidr%26%23xF3%3Bxido%20de%20Alum%26%23xED%3Bnio)%3A%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20de%20um%20anti%26%23xE1%3Bcido%20(hidr%26%23xF3%3Bxido%20de%20magn%26%23xE9%3Bsio%2F%20hidr%26%23xF3%3Bxido%20de%20alum%26%23xED%3Bnio)%20e%20tadalafila%20reduziu%20a%20velocidade%20aparente%20de%20absor%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%20sem%20alterar%20a%20sua%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC).%3Cbr%3E%20%3Cbr%3E%20Aspirina%26%23xAE%3B%3A%20tadalafila%20n%26%23xE3%3Bo%20potencializou%20o%20aumento%20do%20tempo%20de%20sangramento%20causado%20pela%20Aspirina%26%23xAE%3B.%3Cbr%3E%20%3Cbr%3E%20Varfarina%20(Substrato%20do%20CYP2C9)%3A%20tadalafila%20n%26%23xE3%3Bo%20teve%20efeito%20clinicamente%20significativo%20na%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20%26%23xE0%3B%20S-%20varfarina%20ou%20R-varfarina%2C%20nem%20afetou%20as%20altera%26%23xE7%3B%26%23xF5%3Bes%20no%20tempo%20de%20protrombina%20induzidas%20pela%20varfarina.%3Cbr%3E%20%3Cbr%3E%20Teofilina%20(Substrato%20do%20CYP1A2)%3A%20tadalafila%20n%26%23xE3%3Bo%20teve%20efeito%20clinicamente%20significativo%20na%20farmacocin%26%23xE9%3Btica%20ou%20farmacodin%26%23xE2%3Bmica%20da%20teofilina.%3Cbr%3E%20N%26%23xE3%3Bo%20foram%20conduzidos%20estudos%20cl%26%23xED%3Bnicos%20com%20o%20prop%26%23xF3%3Bsito%20de%20investigar%20poss%26%23xED%3Bveis%20intera%26%23xE7%3B%26%23xF5%3Bes%20entre%20tadalafila%20e%20plantas%20medicinais%2C%20nicotina%2C%20testes%20laboratoriais%20e%20n%26%23xE3%3Bo%20laboratoriais.%3Cbr%3E%20_____________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20N%26%23xE3%3Bo%20%26%23xE9%3B%20esperado%20que%20a%20tadalafila%20causa%20inibi%26%23xE7%3B%26%23xE3%3Bo%20ou%20indu%26%23xE7%3B%26%23xE3%3Bo%20clinicamente%20significante%20do%20clearance%20de%20drogas%20metabolizadas%20pelas%20isoformas%20do%20CYP450.%20Estudos%20confirmaram%20que%20a%20tadalafila%20n%26%23xE3%3Bo%20inibe%20ou%20induz%20as%20isoformas%20do%20CYP450%2C%20incluindo%20CYP3A4%2C%20CYP1A2%2C%20CYP2D6%2C%20CYP2E1%2C%20CYP2C9%20e%20CYP2C19.%3Cbr%3E%20%3Cbr%3E%20Cetoconazol%3A%20tadalafila%20%26%23xE9%3B%20principalmente%20metabolizada%20pelo%20CYP3A4.%20Um%20inibidor%20seletivo%20do%20CYP3A4%2C%20cetoconazol%20(400%20mg%20diariamente)%2C%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20312%25%20e%20a%20Cm%26%23xE1%3Bx%20em%2022%25%2C%20e%20cetoconazol%20(200%20mg%20diariamente)%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20107%25%20e%20Cm%26%23xE1%3Bx%20em%2015%25%20com%20rela%26%23xE7%3B%26%23xE3%3Bo%20aos%20valores%20de%20AUC%20e%20Cm%26%23xE1%3Bx%20para%20tadalafila%20isoladamente.%3Cbr%3E%20%3Cbr%3E%20Ritonavir%3A%20ritonavir%20(200%20mg%20duas%20vezes%20ao%20dia)%2C%20um%20inibidor%20do%20CYP3A4%2C%202C9%2C%202C19%2C%20E%202D6%2C%20aumentou%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%20124%25%20sem%20altera%26%23xE7%3B%26%23xE3%3Bo%20na%20Cm%26%23xE1%3Bx.%20Embora%20intera%26%23xE7%3B%26%23xF5%3Bes%20espec%26%23xED%3Bficas%20n%26%23xE3%3Bo%20tenham%20sido%20estudadas%2C%20outros%20inibidores%20de%20protease%20do%20HIV%2C%20como%20o%20saquinavir%20e%20outros%20inibidores%20da%20CYP3A4%2C%20tais%20como%20eritromicina%20e%20itraconazol%2C%20provavelmente%20tamb%26%23xE9%3Bm%20aumentariam%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Rifampicina%3A%20um%20indutor%20do%20CYP3A4%2C%20rifampicina%20600%20mg%20diariamente%2C%20reduziu%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20da%20dose%20%26%23xFA%3Bnica%20de%20tadalafila%20em%2088%25%20e%20Cm%26%23xE1%3Bx%20em%2046%25%2C%20com%20rela%26%23xE7%3B%26%23xE3%3Bo%20aos%20valores%20de%20AUC%20para%20tadalafila%20isolada.%20Pode-se%20esperar%20que%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20outros%20indutores%20CYP3A4%20tamb%26%23xE9%3Bm%20possam%20diminuir%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Agentes%20anti-hipertensivos%3A%20tadalafila%20tem%20propriedades%20vasodilatadoras%20sist%26%23xEA%3Bmicas%20e%20pode%20aumentar%20os%20efeitos%20hipotensores%20dos%20agentes%20anti-hipertensivos.%20Adicionalmente%2C%20em%20pacientes%20tomando%20m%26%23xFA%3Bltiplos%20agentes%20anti-%20hipertensivos%2C%20cuja%20hipertens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20bem%20controlada%2C%20redu%26%23xE7%3B%26%23xF5%3Bes%20maiores%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20foram%20observadas.%20Estas%20redu%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20foram%20associadas%20com%20sintomas%20hipotensivos%20na%20grande%20maioria%20dos%20pacientes.%20Um%20apropriado%20aconselhamento%20m%26%23xE9%3Bdico%20deve%20ser%20dado%20aos%20pacientes%20quando%20estes%20s%26%23xE3%3Bo%20tratados%20com%20medicamentos%20anti-hipertensivos%20e%20tadalafila.%20Em%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%2C%20o%20potencial%20para%20a%20tadalafila%20aumentar%20os%20efeitos%20hipotensivos%20dos%20agentes%20anti-hipertensivos%20foi%20examinado.%20As%20classes%20principais%20de%20agentes%20anti-hipertensivos%20foram%20estudadas%2C%20incluindo%20bloqueadores%20de%20canais%20de%20c%26%23xE1%3Blcio%20(amlodipina)%2C%20inibidores%20da%20enzima%20conversora%20de%20angiotensina%20(ECA)%20(enalapril)%2C%20betabloqueadores%20(metoprolol)%2C%20diur%26%23xE9%3Bticos%20tiaz%26%23xED%3Bdicos%20(bendrofluazida)%20e%20bloqueadores%20do%20receptor%20de%20angiotensina%20II%20(v%26%23xE1%3Brios%20tipos%20e%20doses%2C%20sozinhos%20ou%20em%20combina%26%23xE7%3B%26%23xE3%3Bo%20com%20tiazidas%2C%20bloqueadores%20de%20canal%20de%20c%26%23xE1%3Blcio%2C%20betabloqueadores%2C%20e%2Fou%20alfabloqueadores).Tadalafila%20n%26%23xE3%3Bo%20tem%20intera%26%23xE7%3B%26%23xE3%3Bo%20clinicamente%20significante%20com%20nenhuma%20dessas%20classes.%20A%20an%26%23xE1%3Blise%20dos%20estudos%20cl%26%23xED%3Bnicos%20fase%203%20tamb%26%23xE9%3Bm%20n%26%23xE3%3Bo%20mostraram%20diferen%26%23xE7%3Bas%20nos%20eventos%20adversos%20em%20pacientes%20tomando%20tadalafila%20com%20ou%20sem%20medica%26%23xE7%3B%26%23xE3%3Bo%20anti-hipertensiva.%3Cbr%3E%20%3Cbr%3E%20Agentes%20bloqueadores%20alfa-adren%26%23xE9%3Brgicos%3A%20em%20dois%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%2C%20nenhuma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20foi%20observada%20quando%20a%20tadalafila%20foi%20administrada%20em%20indiv%26%23xED%3Bduos%20tomando%20tansulosina%2C%20um%20bloqueador%20seletivo%20alfa-adren%26%23xE9%3Brgico.%20Quando%20tadalafila%20foi%20coadministrada%20em%20indiv%26%23xED%3Bduos%20sadios%20tomando%20doxazosina%20(4-8%20mg%20diariamente)%2C%20um%20bloqueador%20alfa-adren%26%23xE9%3Brgico%2C%20houve%20um%20aumento%20dos%20efeitos%20hipotensores%20da%20doxazosina.%20O%20n%26%23xFA%3Bmero%20de%20pacientes%20com%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20em%20p%26%23xE9%3B%2C%20potencialmente%20clinicamente%20significativa%2C%20foi%20maior%20para%20esta%20combina%26%23xE7%3B%26%23xE3%3Bo.%20Nestes%20estudos%20de%20farmacologia%20cl%26%23xED%3Bnica%20houve%20sintomas%20associados%20com%20a%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20arterial%20incluindo%20s%26%23xED%3Bncope.%20Doses%20mais%20baixas%20de%20doxazosina%20n%26%23xE3%3Bo%20foram%20estudadas.%20Quando%20tadalafila%20%26%23xE9%3B%20administrada%20concomitantemente%20com%20um%20alfa-bloqueador%2C%20os%20pacientes%20devem%20estar%20est%26%23xE1%3Bveis%20com%20a%20terapia%20com%20alfa-bloqueador%20antes%20de%20iniciar%20o%20tratamento%20com%20tadalafila.%20%3Cbr%3E%20%3Cbr%3E%20%26%23xC1%3Blcool%3A%20tadalafila%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20alco%26%23xF3%3Blicas%20e%20o%20%26%23xE1%3Blcool%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%20Em%20altas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C7%20g%2FKg)%2C%20a%20adi%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20n%26%23xE3%3Bo%20induziu%20diminui%26%23xE7%3B%26%23xE3%3Bo%20estatisticamente%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea.%20Em%20alguns%20indiv%26%23xED%3Bduos%2C%20foram%20observadas%20tontura%20postural%20e%20hipotens%26%23xE3%3Bo%20ortost%26%23xE1%3Btica.%20Quando%20a%20tadalafila%20foi%20administrada%20com%20baixas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C6%20g%2FKg)%2C%20hipotens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20observada%20e%20tonturas%20ocorreram%20com%20frequ%26%23xEA%3Bncia%20similar%20ao%20%26%23xE1%3Blcool%20administrado%20isoladamente.%3Cbr%3E%20%3Cbr%3E%20Antagonistas%20H2%3A%20um%20aumento%20no%20pH%20g%26%23xE1%3Bstrico%20resultante%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nizatidina%20n%26%23xE3%3Bo%20teve%20efeito%20significante%20na%20farmacocin%26%23xE9%3Btica%20de%20tadalafila.%3Cbr%3E%20%3Cbr%3E%20Anti%26%23xE1%3Bcidos%20(hidr%26%23xF3%3Bxido%20de%20magn%26%23xE9%3Bsio%2Fhidr%26%23xF3%3Bxido%20de%20alum%26%23xED%3Bnio)%3A%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20de%20um%20anti%26%23xE1%3Bcido%20(hidr%26%23xF3%3Bxido%20de%20magn%26%23xE9%3Bsio%2Fhidr%26%23xF3%3Bxido%20de%20alum%26%23xED%3Bnio)%20e%20tadalafila%20reduziu%20a%20velocidade%20aparente%20de%20absor%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%20sem%20alterar%20a%20sua%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC).%3Cbr%3E%20%3Cbr%3E%20Aspirina%26%23xAE%3B%3A%20tadalafila%20n%26%23xE3%3Bo%20potencializou%20o%20aumento%20do%20tempo%20de%20sangramento%20causado%20pela%20Aspirina%26%23xAE%3B.%3Cbr%3E%20%3Cbr%3E%20Varfarina%20(substrato%20do%20CYP2C9)%3A%20tadalafila%20n%26%23xE3%3Bo%20teve%20efeito%20clinicamente%20significativo%20na%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%20%26%23xE0%3BS-varfarina%20ou%20R-varfarina%2C%20nem%20afetou%20as%20altera%26%23xE7%3B%26%23xF5%3Bes%20no%20tempo%20de%20protrombina%20induzidas%20pela%20varfarina.%3Cbr%3E%20%3Cbr%3E%20Teofilina%20(substrato%20da%20CYP1A2)%3A%20tadalafila%20n%26%23xE3%3Bo%20teve%20efeito%20clinicamente%20significante%20na%20farmacocin%26%23xE9%3Btica%20ou%20farmacodin%26%23xE2%3Bmica%20da%20teofilina.%3Cbr%3E%20N%26%23xE3%3Bo%20foram%20conduzidos%20estudos%20cl%26%23xED%3Bnicos%20com%20o%20prop%26%23xF3%3Bsito%20de%20investigar%20poss%26%23xED%3Bveis%20intera%26%23xE7%3B%26%23xF5%3Bes%20entre%20tadalafila%20e%20plantas%20medicinais%2C%20nicotina%2C%20testes%20laboratoriais%20e%20n%26%23xE3%3Bo%20laboratoriais.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ERea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20%2F%20efeitos%20colaterais%20de%20Tadalafila%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20A%20tadalafila%20foi%20administrada%20a%20mais%20de%206.550%20homens%20durante%20os%20estudos%20cl%26%23xED%3Bnicos%20ao%20redor%20do%20mundo.%20Em%20estudos%20cl%26%23xED%3Bnicos%20com%20tadalafila%20administrada%20uma%20vez%20ao%20dia%2C%20um%20total%20de%20716%2C%20389%20e%20115%20pacientes%20foram%20tratados%20por%2C%20pelo%20menos%2C%206%20meses%2C%201%20e%202%20anos%20respectivamente.%20Em%20tr%26%23xEA%3Bs%20estudos%20cl%26%23xED%3Bnicos%20placebo-controlados%20de%20fase%203%2C%20de%2012%20ou%2024%20semanas%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%2C%20a%20idade%20m%26%23xE9%3Bdia%20dos%20pacientes%20era%20de%2058%20anos%20(variando%20de%2021%20a%2082%20anos)%20e%20a%20taxa%20de%20descontinua%26%23xE7%3B%26%23xE3%3Bo%20devido%20a%20eventos%20adversos%20em%20pacientes%20tratados%20com%20tadalafila%20foi%20de%204%2C1%25%2C%20comparada%20a%202%2C8%25%20de%20pacientes%20tratados%20com%20placebo.%3Cbr%3E%20%3Cbr%3E%20Durante%20os%20estudos%20cl%26%23xED%3Bnicos%20para%20o%20tratamento%20de%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%20com%20o%20uso%20de%20tadalafila%205%20mg%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Comum%20(%26gt%3B%201%25%20e%20%26lt%3B%2010%25)%3A%20dor%20lombar%2C%20dispepsia%2C%20rubor%20facial%2C%20mialgia%20e%20congest%26%23xE3%3Bo%20nasal.%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Incomum%20(%26gt%3B%200%2C1%25%20e%20%26lt%3B%201%25)%3A%20dispneia.%3Cbr%3E%20%3Cbr%3E%20Durante%20os%20estudos%20cl%26%23xED%3Bnicos%20para%20o%20tratamento%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%20com%20o%20uso%20de%20tadalafila%205%20mg%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Comum%20(%26gt%3B%201%25%20e%20%26lt%3B%2010%25)%3A%20cefaleia%2C%20dispepsia%2C%20mialgia%2C%20dor%20nas%20extremidades%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20No%20acompanhamento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%2C%20os%20seguintes%20eventos%20adversos%20que%20foram%20relatados%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20nos%20pacientes%20usando%20tadalafila%20inclu%26%23xED%3Bram%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Muito%20Rara%20(%26lt%3B%200%2C01%25)%3A%3Cbr%3E%20Corpo%20como%20um%20todo%3A%20rea%26%23xE7%3B%26%23xF5%3Bes%20de%20hipersensibilidade%2C%20incluindo%20erup%26%23xE7%3B%26%23xE3%3Bo%20cut%26%23xE2%3Bnea%2C%20urtic%26%23xE1%3Bria%2C%20edema%20facial%2C%20s%26%23xED%3Bndrome%20de%20Stevens-Johnson%20e%20dermatite%20esfoliativa.%3Cbr%3E%20%3Cbr%3E%20Cardiovascular%20e%20Cerebrovascular%3A%20eventos%20cardiovasculares%20graves%2C%20incluindo%20infarto%20do%20mioc%26%23xE1%3Brdio%2C%20morte%20s%26%23xFA%3Bbita%20card%26%23xED%3Baca%2C%20acidente%20vascular%20cerebral%2C%20dor%20tor%26%23xE1%3Bcica%2C%20palpita%26%23xE7%3B%26%23xF5%3Bes%20e%20taquicardia%20foram%20relatados%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20tadalafila.%20A%20maioria%20dos%20pacientes%20que%20relataram%20estes%20eventos%20tinha%20fatores%20de%20risco%20cardiovascular%20pr%26%23xE9%3B-existentes.%20Entretanto%2C%20n%26%23xE3%3Bo%20se%20pode%20determinar%20definitivamente%20se%20estes%20eventos%20s%26%23xE3%3Bo%20relacionados%20diretamente%20a%20estes%20fatores%20de%20risco%2C%20%26%23xE0%3B%20tadalafila%2C%20%26%23xE0%3B%20atividade%20sexual%2C%20ou%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20e%20outros%20fatores.%20Hipotens%26%23xE3%3Bo%20(mais%20comumente%20relatada%20quando%20a%20tadalafila%20%26%23xE9%3B%20usada%20por%20pacientes%20que%20j%26%23xE1%3B%20est%26%23xE3%3Bo%20tomando%20agentes%20anti-hipertensivos)%2C%20hipertens%26%23xE3%3Bo%20e%20s%26%23xED%3Bncope.%3Cbr%3E%20%3Cbr%3E%20Gastrointestinal%3A%20dor%20abdominal%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20Pele%20e%20Tecidos%20Subcut%26%23xE2%3Bneos%3A%20hiperidrose.%3Cbr%3E%20%3Cbr%3E%20Sentidos%20especiais%3A%20vis%26%23xE3%3Bo%20borrada%2C%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%2C%20oclus%26%23xE3%3Bo%20da%20veia%20retiniana%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20(altera%26%23xE7%3B%26%23xE3%3Bo)%20do%20campo%20visual.%3Cbr%3E%20A%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(caracterizada%20pela%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20vis%26%23xE3%3Bo%2C%20implicando%20em%20perda%20permanente%20da%20vis%26%23xE3%3Bo)%20foi%20um%20evento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20relatado%20raramente%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20medicamentos%20inibidores%20da%20PDE5.%20A%20maioria%20desses%20pacientes%2C%20por%26%23xE9%3Bm%20n%26%23xE3%3Bo%20todos%2C%20tinham%20fatores%20de%20riscos%20basais%20anat%26%23xF4%3Bmicos%20ou%20vasculares%20para%20desenvolverem%20a%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%2C%20incluindo%2C%20mas%20n%26%23xE3%3Bo%20necessariamente%20limitada%20%26%23xE0%3B%3A%20baixa%20rela%26%23xE7%3B%26%23xE3%3Bo%20entre%20o%20di%26%23xE2%3Bmetro%20da%20escava%26%23xE7%3B%26%23xE3%3Bo%20e%20o%20di%26%23xE2%3Bmetro%20da%20pupila%20(cup%20to%20disc%20%26%23x96%3B%20%26%23x93%3Bcrowded%20disc%26%23x94%3B)%2C%20idade%20acima%20dos%2050%20anos%2C%20diabetes%2C%20hipertens%26%23xE3%3Bo%2C%20doen%26%23xE7%3Ba%20arterial%20coronariana%2C%20hiperlipidemia%20e%20tabagismo.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20dos%20inibidores%20da%20PDE5%20aos%20fatores%20de%20risco%20basais%20vasculares%20ou%20defeitos%20anat%26%23xF4%3Bmicos%20do%20paciente%2C%20ou%20a%20combina%26%23xE7%3B%26%23xE3%3Bo%20desses%20fatores%20ou%20a%20outros%20fatores.%20Atualmente%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20a%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20est%26%23xE1%3B%20relacionada%20diretamente%20ao%20uso%20de%20inibidores%20da%20PDE5%20ou%20a%20outros%20fatores.%20Os%20m%26%23xE9%3Bdicos%20devem%20orientar%20os%20pacientes%20a%20interromperem%20o%20uso%20de%20tadalafila%20e%20procurarem%20aux%26%23xED%3Blio%20m%26%23xE9%3Bdico%20no%20caso%20de%20perda%20repentina%20da%20vis%26%23xE3%3Bo.%20Os%20m%26%23xE9%3Bdicos%20devem%20informar%20seus%20pacientes%20que%20indiv%26%23xED%3Bduos%20que%20j%26%23xE1%3B%20apresentaram%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20t%26%23xEA%3Bm%20um%20risco%20maior%20em%20apresentar%20esses%20eventos.%3Cbr%3E%20%3Cbr%3E%20Urogenital%3A%20priapismo%20e%20ere%26%23xE7%3B%26%23xE3%3Bo%20prolongada.%3Cbr%3E%20%3Cbr%3E%20Sistema%20nervoso%3A%20enxaqueca.%3Cbr%3E%20%3Cbr%3E%20Sistema%20respirat%26%23xF3%3Brio%3A%20epistaxe.%3Cbr%3E%20%3Cbr%3E%20Otol%26%23xF3%3Bgicos%3A%20na%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20foram%20relatados%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20da%20audi%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20Em%20alguns%20casos%2C%20foram%20relatadas%20condi%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdicas%20e%20outros%20fatores%20que%20podem%20igualmente%20ter%20causado%20eventos%20adversos%20otol%26%23xF3%3Bgicos.%20Em%20muitos%20casos%2C%20a%20informa%26%23xE7%3B%26%23xE3%3Bo%20no%20acompanhamento%20m%26%23xE9%3Bdico%20foi%20limitada.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20relacionados%20diretamente%20ao%20uso%20de%20tadalafila%2C%20a%20fatores%20de%20risco%20subjacentes%20do%20paciente%20para%20a%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%2C%20uma%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20fatores%20ou%20a%20outros%20fatores.%3Cbr%3E%20%3Cbr%3E%20Aten%26%23xE7%3B%26%23xE3%3Bo%3A%20este%20produto%20%26%23xE9%3B%20um%20medicamento%20que%20possui%20nova%20concentra%26%23xE7%3B%26%23xE3%3Bo%20e%20nova%20indica%26%23xE7%3B%26%23xE3%3Bo%20terap%26%23xEA%3Butica%20no%20pa%26%23xED%3Bs%20e%2C%20embora%20as%20pesquisas%20tenham%20indicado%20efic%26%23xE1%3Bcia%20e%20seguran%26%23xE7%3Ba%20aceit%26%23xE1%3Bveis%2C%20mesmo%20que%20indicado%20e%20utilizado%20corretamente%2C%20podem%20ocorrer%20eventos%20adversos%20imprevis%26%23xED%3Bveis%20ou%20desconhecidos.%20Nesse%20caso%2C%20notifique%20os%20eventos%20adversos%20pelo%20Sistema%20de%20Notifica%26%23xE7%3B%26%23xF5%3Bes%20em%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20%26%23x96%3B%20NOTIVISA%2C%20dispon%26%23xED%3Bvel%20em%3A%20www.anvisa.gov.br%2Fhotsite%2Fnotivisa%2Findex.htm%2C%20ou%20para%20a%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20Estadual%20ou%20Municipal.%3Cbr%3E%20______________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20Mais%20de%201.000%20pacientes%20foram%20tratados%20por%20mais%20de%20um%20ano%20e%20mais%20de%201.300%20pacientes%20foram%20tratados%20por%20mais%20de%206%20meses.%3Cbr%3E%20Em%20estudos%20cl%26%23xED%3Bnicos%20placebo-controlados%20de%20fase%203%2C%20a%20taxa%20de%20descontinua%26%23xE7%3B%26%23xE3%3Bo%20devido%20a%20eventos%20adversos%20em%20pacientes%20tratados%20com%20tadalafila%20foi%20de%203%2C1%25%2C%20comparada%20a%201%2C4%25%20de%20pacientes%20tratados%20com%20placebo.%20Nestes%20estudos%2C%20os%20eventos%20adversos%20relatados%20com%20tadalafila%20foram%20geralmente%20leves%20ou%20moderados%2C%20transit%26%23xF3%3Brios%20e%20diminu%26%23xED%3Bram%20com%20a%20continua%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento.%3Cbr%3E%20%3Cbr%3E%20Nos%20estudos%20cl%26%23xED%3Bnicos%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Muito%20Comum%20(%26gt%3B10%25)%3A%20dor%20de%20cabe%26%23xE7%3Ba.%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Comum%20(%26gt%3B1%25%20e%20%26lt%3B10%25)%3A%20dor%20lombar%2C%20tontura%2C%20dispepsia%2C%20rubor%20facial%2C%20mialgia%20e%20congest%26%23xE3%3Bo%20nasal.%20%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Incomum%20(%26gt%3B%200%2C1%25%20e%20%26lt%3B%201%25)%3A%20hiperemia%20conjuntival%2C%20sensa%26%23xE7%3B%26%23xF5%3Bes%20descritas%20como%20dor%20no%20olho%2C%20incha%26%23xE7%3Bo%20das%20p%26%23xE1%3Blpebras%20e%20dispneia.%3Cbr%3E%20%3Cbr%3E%20No%20acompanhamento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%2C%20os%20seguintes%20eventos%20adversos%20que%20foram%20relatados%20muito%20raramente%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20nos%20pacientes%20usando%20tadalafila%20inclu%26%23xED%3Bram%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Muito%20Rara%20(%26lt%3B%200%2C01%25)%3A%3Cbr%3E%20Corpo%20como%20um%20todo%3A%20rea%26%23xE7%3B%26%23xF5%3Bes%20de%20hipersensibilidade%2C%20incluindo%20erup%26%23xE7%3B%26%23xE3%3Bo%20cut%26%23xE2%3Bnea%2C%20urtic%26%23xE1%3Bria%2C%20edema%20facial%2C%20s%26%23xED%3Bndrome%20de%20Stevens-Johnson%20e%20dermatite%20esfoliativa.%3Cbr%3E%20Cardiovascular%20e%20cerebrovascular%3A%20eventos%20cardiovasculares%20graves%2C%20incluindo%20infarto%20do%20mioc%26%23xE1%3Brdio%2C%20morte%20s%26%23xFA%3Bbita%20card%26%23xED%3Baca%2C%20acidente%20vascular%20cerebral%2C%20dor%20tor%26%23xE1%3Bcica%2C%20palpita%26%23xE7%3B%26%23xF5%3Bes%20e%20taquicardia%20foram%20relatados%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20tadalafila.%20A%20maioria%20dos%20pacientes%20que%20relataram%20estes%20eventos%20tinham%20fatores%20de%20risco%20cardiovascular%20pr%26%23xE9%3B-existentes.%20Entretanto%2C%20n%26%23xE3%3Bo%20se%20pode%20determinar%20definitivamente%20se%20estes%20eventos%20s%26%23xE3%3Bo%20relacionados%20diretamente%20a%20estes%20fatores%20de%20risco%2C%20%26%23xE0%3B%20tadalafila%2C%20%26%23xE0%3B%20atividade%20sexual%2C%20ou%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20e%20outros%20fatores.%20Hipotens%26%23xE3%3Bo%20(mais%20comumente%20relatada%20quando%20a%20tadalafila%20%26%23xE9%3B%20usada%20por%20pacientes%20que%20j%26%23xE1%3B%20est%26%23xE3%3Bo%20tomando%20agentes%20anti-hipertensivos)%2C%20hipertens%26%23xE3%3Bo%20e%20s%26%23xED%3Bncope.%3Cbr%3E%20%3Cbr%3E%20Gastrointestinal%3A%20dor%20abdominal%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20Pele%20e%20tecidos%20subcut%26%23xE2%3Bneos%3A%20hiperidrose.%3Cbr%3E%20%3Cbr%3E%20Sentidos%20especiais%3A%20vis%26%23xE3%3Bo%20borrada%2C%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%2C%20oclus%26%23xE3%3Bo%20da%20veia%20retiniana%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20(altera%26%23xE7%3B%26%23xE3%3Bo)%20do%20campo%20visual.%3Cbr%3E%20%3Cbr%3E%20A%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(caracterizada%20pela%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20vis%26%23xE3%3Bo%2C%20implicando%20em%20perda%20permanente%20da%20vis%26%23xE3%3Bo)%20foi%20um%20evento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20relatado%20raramente%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20medicamentos%20inibidores%20da%20PDE5.%20A%20maioria%20desses%20pacientes%2C%20por%26%23xE9%3Bm%20n%26%23xE3%3Bo%20todos%2C%20tinham%20fatores%20de%20riscos%20basais%20anat%26%23xF4%3Bmicos%20ou%20vasculares%20para%20desenvolverem%20a%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%2C%20incluindo%2C%20mas%20n%26%23xE3%3Bo%20necessariamente%20limitada%20%26%23xE0%3B%3A%20baixa%20rela%26%23xE7%3B%26%23xE3%3Bo%20entre%20o%20di%26%23xE2%3Bmetro%20da%20escava%26%23xE7%3B%26%23xE3%3Bo%20e%20o%20di%26%23xE2%3Bmetro%20da%20pupila%20(cup%20to%20disc%20%26%23x96%3B%20%26%23x93%3Bcrowded%20disc%26%23x94%3B)%2C%20idade%20acima%20dos%2050%20anos%2C%20diabetes%2C%20hipertens%26%23xE3%3Bo%2C%20doen%26%23xE7%3Ba%20arterial%20coronariana%2C%20hiperlipidemia%20e%20tabagismo.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20dos%20inibidores%20da%20PDE5%2C%20aos%20fatores%20de%20risco%20basais%20vasculares%2C%20defeitos%20anat%26%23xF4%3Bmicos%20do%20paciente%2C%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20desses%20fatores%20ou%20a%20outros%20fatores.%20Atualmente%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20a%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20est%26%23xE1%3B%20relacionada%20diretamente%20ao%20uso%20de%20inibidores%20da%20PDE5%20ou%20a%20outros%20fatores.%20Os%20m%26%23xE9%3Bdicos%20devem%20orientar%20os%20pacientes%20a%20interromperem%20o%20uso%20de%20tadalafila%20e%20procurarem%20aux%26%23xED%3Blio%20m%26%23xE9%3Bdico%20no%20caso%20de%20perda%20repentina%20da%20vis%26%23xE3%3Bo.%20Os%20m%26%23xE9%3Bdicos%20devem%20informar%20seus%20pacientes%20que%20indiv%26%23xED%3Bduos%20que%20j%26%23xE1%3B%20apresentaram%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20t%26%23xEA%3Bm%20um%20risco%20maior%20em%20apresentar%20esses%20eventos.%3Cbr%3E%20%3Cbr%3E%20Urogenital%3A%20priapismo%20e%20ere%26%23xE7%3B%26%23xE3%3Bo%20prolongada.%3Cbr%3E%20%3Cbr%3E%20Sistema%20nervoso%3A%20enxaqueca.%3Cbr%3E%20%3Cbr%3E%20Sistema%20respirat%26%23xF3%3Brio%3A%20epistaxe.%3Cbr%3E%20%3Cbr%3E%20Otol%26%23xF3%3Bgicos%3A%20na%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20foram%20relatados%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20da%20audi%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20Em%20alguns%20casos%2C%20foram%20relatadas%20condi%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdicas%20e%20outros%20fatores%20que%20podem%20igualmente%20ter%20causado%20eventos%20adversos%20otol%26%23xF3%3Bgicos.%20Em%20muitos%20casos%2C%20a%20informa%26%23xE7%3B%26%23xE3%3Bo%20no%20acompanhamento%20m%26%23xE9%3Bdico%20foi%20limitada.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20relacionados%20diretamente%20ao%20uso%20de%20tadalafila%2C%20a%20fatores%20de%20risco%20subjacentes%20do%20paciente%20para%20a%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%2C%20uma%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20fatores%20ou%20a%20outros%20fatores.%3Cbr%3E%20%3Cbr%3E%20Em%20caso%20de%20eventos%20adversos%2C%20notifique%20ao%20Sistema%20de%20Notifica%26%23xE7%3B%26%23xF5%3Bes%20em%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20%26%23x96%3B%20NOTIVISA%2C%20dispon%26%23xED%3Bvel%20em%20www.anvisa.gov.br%2Fhotsite%2Fnotivisa%2Findex.htm%2C%20ou%20para%20a%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20Estadual%20ou%20Municipal.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ETadalafila%20%26%23x2013%3B%20Posologia%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20A%20dose%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%205%20mg%2C%20administrada%20uma%20vez%20ao%20dia%2C%20aproximadamente%20no%20mesmo%20hor%26%23xE1%3Brio.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ocorrer%20a%20crit%26%23xE9%3Brio%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%3A%20A%20dose%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%205%20mg%2C%20administrada%20uma%20vez%20ao%20dia%2C%20aproximadamente%20no%20mesmo%20hor%26%23xE1%3Brio.%3Cbr%3E%20%3Cbr%3E%20Homens%20com%20insufici%26%23xEA%3Bncia%20renal%3A%20N%26%23xE3%3Bo%20%26%23xE9%3B%20necess%26%23xE1%3Brio%20o%20ajuste%20de%20dose%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20leve%20ou%20moderada.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20uma%20vez%20ao%20dia%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendada%20para%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20grave.%3Cbr%3E%20_________________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20A%20dose%20m%26%23xE1%3Bxima%20recomendada%20de%20tadalafila%20%26%23xE9%3B%2020%20mg%2C%20tomada%20antes%20da%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20e%20independente%20das%20refei%26%23xE7%3B%26%23xF5%3Bes.%20A%20frequ%26%23xEA%3Bncia%20m%26%23xE1%3Bxima%20de%20dose%20recomendada%20%26%23xE9%3B%20uma%20vez%20ao%20dia.%20A%20tadalafila%20provou%20ser%20eficaz%20a%20partir%20de%2030%20minutos%20ap%26%23xF3%3Bs%20sua%20administra%26%23xE7%3B%26%23xE3%3Bo%2C%20por%20at%26%23xE9%3B%2036%20horas.%20Pacientes%20podem%20iniciar%20a%20atividade%20sexual%20em%20tempos%20vari%26%23xE1%3Bveis%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20administra%26%23xE7%3B%26%23xE3%3Bo%2C%20de%20maneira%20a%20determinar%20seu%20pr%26%23xF3%3Bprio%20intervalo%20%26%23xF3%3Btimo%20de%20resposta.%3C%2Fp%3E%0A%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%3C%2Famp-ad%3E%0A%3Ch2%3ESuper%20dosagem%3C%2Fh2%3E%0A%3Cp%3EDoses%20%26%23xFA%3Bnicas%20de%20at%26%23xE9%3B%20500%20mg%20de%20tadalafila%20foram%20administradas%20a%20indiv%26%23xED%3Bduos%20sadios%20e%20doses%20m%26%23xFA%3Bltiplas%20di%26%23xE1%3Brias%20de%20at%26%23xE9%3B%20100%20mg%20de%20tadalafila%2C%20foram%20administradas%20a%20pacientes.%20Os%20eventos%20adversos%20foram%20similares%20%26%23xE0%3Bqueles%20observados%20com%20doses%20mais%20baixas.%20Em%20casos%20de%20superdose%2C%20medidas%20de%20suporte%20padr%26%23xE3%3Bo%20devem%20ser%20adotadas%20conforme%20necess%26%23xE1%3Brio.%20Hemodi%26%23xE1%3Blise%20contribui%20de%20modo%20desprez%26%23xED%3Bvel%20para%20a%20elimina%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila.%3Cbr%3E%20Em%20caso%20de%20intoxica%26%23xE7%3B%26%23xE3%3Bo%20ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ECaracteristicas%20farmalogicas%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20Descri%26%23xE7%3B%26%23xE3%3Bo%3A%20tadalafila%2C%20um%20tratamento%20oral%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20%26%23xE9%3B%20um%20inibidor%20revers%26%23xED%3Bvel%2C%20potente%20e%20seletivo%20da%20guanosina%20monofosfato%20c%26%23xED%3Bclica%20(GMPc)%20%26%23x2013%3B%20fosfodiesterase%20espec%26%23xED%3Bfica%20tipo%205%20(PDE5).%20A%20tadalafila%20tem%20f%26%23xF3%3Brmula%20emp%26%23xED%3Brica%20C22H19N3O4%20representando%20um%20peso%20molecular%20de%20389%2C41.%20O%20nome%20qu%26%23xED%3Bmico%20%26%23xE9%3B%20pirazino%5B1%26%23x92%3B%2C2%26%23x92%3B%3A1%2C6%5Dpirido%5B3%2C4-b%5Dindol-1%2C4-diona%2C6-(1%2C3-benzodioxol-5-il)-2%2C3%2C6%2C7%2C12%2C12a-hexahidro-2-metil-%2C%20(6R%2C12aR).%20%26%23xC9%3B%20um%20s%26%23xF3%3Blido%20cristalino%20praticamente%20insol%26%23xFA%3Bvel%20em%20%26%23xE1%3Bgua%20e%20muito%20pouco%20sol%26%23xFA%3Bvel%20em%20etanol.%3Cbr%3E%20%3Cbr%3E%20Propriedades%20farmacodin%26%23xE2%3Bmicas%3A%3Cbr%3E%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20Quando%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual%20causa%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20local%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE5%20pela%20tadalafila%20produz%20n%26%23xED%3Bveis%20elevados%20de%20GMPc%20no%20corpo%20cavernoso.%20Isso%20resulta%20no%20relaxamento%20da%20musculatura%20lisa%20e%20na%20entrada%20de%20sangue%20nos%20tecidos%20penianos%2C%20produzindo%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20Tadalafila%20n%26%23xE3%3Bo%20tem%20efeito%20na%20aus%26%23xEA%3Bncia%20de%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%3Cbr%3E%20%3Cbr%3E%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%3A%20O%20efeito%20da%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE5%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20de%20GMPc%20no%20corpo%20cavernoso%20e%20nas%20art%26%23xE9%3Brias%20pulmonares%20%26%23xE9%3B%20tamb%26%23xE9%3Bm%20observado%20na%20musculatura%20lisa%20da%20pr%26%23xF3%3Bstata%2C%20da%20bexiga%20e%20de%20seus%20suprimentos%20vasculares.%20O%20relaxamento%20vascular%20resulta%20no%20aumento%20da%20perfus%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20e%20pode%20reduzir%20os%20sintomas%20da%20HPB.%20O%20relaxamento%20da%20musculatura%20lisa%20da%20pr%26%23xF3%3Bstata%20e%20da%20bexiga%20podem%20complementar%20estes%20efeitos%20vasculares.%3Cbr%3E%20Estudos%20in%20vitro%20mostraram%20que%20tadalafila%20%26%23xE9%3B%20um%20inibidor%20seletivo%20da%20PDE5%2C%20encontrada%20na%20musculatura%20lisa%20do%20corpo%20cavernoso%2C%20pr%26%23xF3%3Bstata%20e%20bexiga%2C%20bem%20como%20em%20musculatura%20lisa%20vascular%20e%20visceral%2C%20musculoesquel%26%23xE9%3Btico%2C%20plaquetas%2C%20rins%2C%20pulm%26%23xF5%3Bes%2C%20cerebelo%20e%20p%26%23xE2%3Bncreas.%20O%20efeito%20da%20tadalafila%20%26%23xE9%3B%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20outras%20fosfodiesterases.%20A%20tadalafila%20%26%23xE9%3B%20mais%20que%2010.000%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE1%2C%20PDE2%2C%20PDE4%20e%20PDE7%2C%20enzimas%20que%20s%26%23xE3%3Bo%20encontradas%20no%20cora%26%23xE7%3B%26%23xE3%3Bo%2C%20c%26%23xE9%3Brebro%2C%20vasos%20sangu%26%23xED%3Bneos%2C%20f%26%23xED%3Bgado%2C%20leuc%26%23xF3%3Bcitos%2C%20musculoesquel%26%23xE9%3Btico%20e%20outros%20%26%23xF3%3Brg%26%23xE3%3Bos.%20A%20tadalafila%20%26%23xE9%3B%20mais%20que%2010.000%20vezes%20mais%20potente%20para%20PDE5%20que%20para%20PDE3%2C%20uma%20enzima%20encontrada%20no%20cora%26%23xE7%3B%26%23xE3%3Bo%20e%20vasos%20sangu%26%23xED%3Bneos.%20Esta%20seletividade%20para%20a%20PDE5%20sobre%20PDE3%20%26%23xE9%3B%20importante%20porque%20PDE3%20%26%23xE9%3B%20uma%20enzima%20envolvida%20na%20contratilidade%20card%26%23xED%3Baca.%20Adicionalmente%2C%20a%20tadalafila%20%26%23xE9%3B%20aproximadamente%20700%20vezes%20mais%20potente%20para%20PDE5%20que%20para%20PDE6%2C%20uma%20enzima%20encontrada%20na%20retina%20e%20que%20%26%23xE9%3B%20respons%26%23xE1%3Bvel%20pela%20fototransdu%26%23xE7%3B%26%23xE3%3Bo.%20A%20tadalafila%20%26%23xE9%3B%20tamb%26%23xE9%3Bm%20mais%20que%209.000%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE8%2C%20PDE9%2C%20e%20PDE10%3B%20e%2014%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE11.%20A%20distribui%26%23xE7%3B%26%23xE3%3Bo%20nos%20tecidos%20e%20os%20efeitos%20fisiol%26%23xF3%3Bgicos%20da%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE8%20at%26%23xE9%3B%20PDE11%20n%26%23xE3%3Bo%20foram%20esclarecidos.%3Cbr%3E%20%3Cbr%3E%20Propriedades%20farmacocin%26%23xE9%3Bticas%3A%3Cbr%3E%20Absor%26%23xE7%3B%26%23xE3%3Bo%3A%20a%20tadalafila%20%26%23xE9%3B%20rapidamente%20absorvida%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%20e%20a%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20observada%20(Cm%26%23xE1%3Bx)%20%26%23xE9%3B%20atingida%20em%20um%20tempo%20m%26%23xE9%3Bdio%20de%202%20horas%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo.%20A%20biodisponibilidade%20absoluta%20da%20tadalafila%20ap%26%23xF3%3Bs%20dose%20oral%20n%26%23xE3%3Bo%20foi%20determinada.%3Cbr%3E%20A%20velocidade%20e%20extens%26%23xE3%3Bo%20da%20absor%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%20n%26%23xE3%3Bo%20s%26%23xE3%3Bo%20influenciadas%20pela%20alimenta%26%23xE7%3B%26%23xE3%3Bo%2C%20portanto%2C%20tadalafila%20pode%20ser%20tomada%20com%20ou%20sem%20alimento.%20O%20per%26%23xED%3Bodo%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20(manh%26%23xE3%3B%20versus%20noite)%20n%26%23xE3%3Bo%20teve%20efeitos%20clinicamente%20relevantes%20sobre%20a%20velocidade%20e%20extens%26%23xE3%3Bo%20da%20absor%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20%3Cbr%3E%20Distribui%26%23xE7%3B%26%23xE3%3Bo%3A%20o%20volume%20de%20distribui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdio%20%26%23xE9%3B%20de%20aproximadamente%2063%20litros%2C%20indicando%20que%20tadalafila%20%26%23xE9%3B%20distribu%26%23xED%3Bda%20nos%20tecidos.%20Em%20concentra%26%23xE7%3B%26%23xF5%3Bes%20terap%26%23xEA%3Buticas%2C%2094%25%20da%20tadalafila%20est%26%23xE1%3B%20ligada%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas.%20Menos%20de%200%2C0005%25%20da%20dose%20administrada%20aparece%20no%20s%26%23xEA%3Bmen%20de%20indiv%26%23xED%3Bduos%20sadios.%3Cbr%3E%20%3Cbr%3E%20Metabolismo%3A%20a%20tadalafila%20%26%23xE9%3B%20predominantemente%20metabolizada%20pelo%20citocromo%20P450%20(CYP)%20isoforma%203A4.%20O%20maior%20metab%26%23xF3%3Blito%20circulante%20%26%23xE9%3B%20a%20glucuronida%20metilcatecol.%20Este%20metab%26%23xF3%3Blito%20%26%23xE9%3B%20pelo%20menos%2013.000%20vezes%20menos%20potente%20que%20a%20tadalafila%20para%20PDE5.%20Consequentemente%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20esperado%20que%20seja%20clinicamente%20ativo%20nas%20concentra%26%23xE7%3B%26%23xF5%3Bes%20observadas%20dos%20metab%26%23xF3%3Blitos.%3Cbr%3E%20%3Cbr%3E%20Elimina%26%23xE7%3B%26%23xE3%3Bo%3A%20o%20clearance%20m%26%23xE9%3Bdio%20para%20a%20tadalafila%20%26%23xE9%3B%202%2C5%20L%2Fh%20e%20a%20meia-vida%20m%26%23xE9%3Bdia%20%26%23xE9%3B%20de%2017%2C5%20horas%20em%20indiv%26%23xED%3Bduos%20sadios.%20A%20tadalafila%20%26%23xE9%3B%20excretada%20predominantemente%20como%20metab%26%23xF3%3Blitos%2C%20principalmente%20nas%20fezes%20(aproximadamente%2061%25%20da%20dose)%20e%2C%20em%20menor%20extens%26%23xE3%3Bo%2C%20na%20urina%20(aproximadamente%2036%25%20da%20dose).%3Cbr%3E%20Num%20intervalo%20de%20dose%20de%202%2C5%20a%2020%20mg%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(%26%23xE1%3Brea%20sob%20a%20curva%20%26%23x2013%3B%20AUC)%20aumenta%20proporcionalmente%20com%20a%20dose.%20As%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20no%20estado%20de%20equil%26%23xED%3Bbrio%20s%26%23xE3%3Bo%20alcan%26%23xE7%3Badas%20dentro%20de%205%20dias%20de%20dose%20%26%23xFA%3Bnica%20di%26%23xE1%3Bria.%20A%20farmacocin%26%23xE9%3Btica%20determinada%20em%20uma%20popula%26%23xE7%3B%26%23xE3%3Bo%20de%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20%26%23xE9%3B%20similar%20%26%23xE0%3B%20farmacocin%26%23xE9%3Btica%20em%20indiv%26%23xED%3Bduos%20sem%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20%3Cbr%3E%20Farmacocin%26%23xE9%3Btica%20em%20popula%26%23xE7%3B%26%23xF5%3Bes%20especiais%3A%3Cbr%3E%20Idosos%3A%20indiv%26%23xED%3Bduos%20idosos%20sadios%20(65%20anos%20ou%20mais)%20tiveram%20um%20clearance%20menor%20de%20tadalafila%2C%20resultando%20em%20uma%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%2025%25%20maior%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20a%20indiv%26%23xED%3Bduos%20sadios%20de%20idade%20entre%2019%20e%2045%20anos.%20Este%20efeito%20da%20idade%20n%26%23xE3%3Bo%20%26%23xE9%3B%20clinicamente%20significativo%20e%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20de%20dose.%3Cbr%3E%20%3Cbr%3E%20Pedi%26%23xE1%3Btricos%3A%20tadalafila%20n%26%23xE3%3Bo%20foi%20avaliada%20em%20indiv%26%23xED%3Bduos%20com%20menos%20de%2018%20anos.%3Cbr%3E%20Insufici%26%23xEA%3Bncia%20Hep%26%23xE1%3Btica%3A%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%20(Child-Pugh%20Classes%20A%20e%20B)%20%26%23xE9%3B%20compar%26%23xE1%3Bvel%20%26%23xE0%3B%20exposi%26%23xE7%3B%26%23xE3%3Bo%20em%20indiv%26%23xED%3Bduos%20sadios.%20N%26%23xE3%3Bo%20existem%20dados%20dispon%26%23xED%3Bveis%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(Child-Pugh%20Classe%20C).%3Cbr%3E%20%3Cbr%3E%20Insufici%26%23xEA%3Bncia%20Renal%3A%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20renal%2C%20incluindo%20aqueles%20em%20hemodi%26%23xE1%3Blise%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20foi%20maior%20que%20em%20indiv%26%23xED%3Bduos%20sadios.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Diabetes%3A%20A%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20pacientes%20com%20diabetes%20foi%20aproximadamente%2019%25%20menor%20que%20o%20valor%20de%20AUC%20para%20indiv%26%23xED%3Bduos%20sadios.%20Esta%20diferen%26%23xE7%3Ba%20na%20exposi%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20de%20dose.%3Cbr%3E%20%3Cbr%3E%20Estudos%20da%20tadalafila%20na%20Frequ%26%23xEA%3Bncia%20Card%26%23xED%3Baca%20e%20Press%26%23xE3%3Bo%20Arterial%3A%20tadalafila%20administrada%20a%20indiv%26%23xED%3Bduos%20sadios%20n%26%23xE3%3Bo%20produziu%20diferen%26%23xE7%3Ba%20significativa%2C%20comparando-se%20ao%20grupo%20placebo%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20sist%26%23xF3%3Blica%20e%20diast%26%23xF3%3Blica%20em%20dec%26%23xFA%3Bbito%20horizontal%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20de%201%2C6%2F0%2C8%20mmHg%2C%20respectivamente)%2C%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20sist%26%23xF3%3Blica%20e%20diast%26%23xF3%3Blica%20em%20p%26%23xE9%3B%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20de%200%2C2%2F4%2C6%20mmHg%2C%20respectivamente)%2C%20e%20n%26%23xE3%3Bo%20houve%20altera%26%23xE7%3B%26%23xE3%3Bo%20significativa%20na%20frequ%26%23xEA%3Bncia%20card%26%23xED%3Baca.%20Efeitos%20maiores%20foram%20relatados%20entre%20indiv%26%23xED%3Bduos%20recebendo%20nitratos%20concomitantemente%20(ver%3Cbr%3E%20CONTRAINDICA%26%23xC7%3B%26%23xD5%3BES).%3Cbr%3E%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xE3%3Bo%20com%20nitratos%3A%20um%20estudo%20foi%20realizado%20para%20avaliar%20o%20n%26%23xED%3Bvel%20de%20intera%26%23xE7%3B%26%23xE3%3Bo%20entre%20nitratos%20e%20a%20tadalafila.%20O%20objetivo%20do%20estudo%20foi%20determinar%20em%20qual%20per%26%23xED%3Bodo%2C%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%2C%20n%26%23xE3%3Bo%20iria%20ocorrer%20uma%20intera%26%23xE7%3B%26%23xE3%3Bo%20aparente%20na%20press%26%23xE3%3Bo%20arterial.%20Os%20pacientes%20envolvidos%20no%20estudo%20(incluindo%20pacientes%20diab%26%23xE9%3Bticos%20e%2F%20ou%20hipertensos%20com%20a%20press%26%23xE3%3Bo%20arterial%20controlada)%20receberam%20diariamente%20doses%20de%2020%20mg%20de%20tadalafila%20ou%20placebo%20durante%207%20dias%20quando%2C%20ent%26%23xE3%3Bo%2C%20receberam%20uma%20%26%23xFA%3Bnica%20dose%20de%200%2C4%20mg%20de%20nitroglicerina%20sublingual%20em%20per%26%23xED%3Bodospr%26%23xE9%3B-determinados%20ap%26%23xF3%3Bs%20a%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila.%20O%20resultado%20deste%20estudo%20demonstrou%20que%20n%26%23xE3%3Bo%20foi%20detectada%20intera%26%23xE7%3B%26%23xE3%3Bo%20ap%26%23xF3%3Bs%2048%20horas%20da%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila.%3Cbr%3E%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20tadalafila%20com%20nitratos%20%26%23xE9%3B%20contraindicada.%20Quando%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nitratos%20for%20extremamente%20necess%26%23xE1%3Bria%20em%20paciente%20que%20tomaram%20tadalafila%2C%20deve%20ser%20considerado%20o%20intervalo%20de%20pelo%20menos%2048%20horas%20ap%26%23xF3%3Bs%20a%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20para%20administrar%20nitratos.%20Nestas%20circunst%26%23xE2%3Bncias%2C%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nitratos%20deve%20ser%20realizada%20sob%20estreita%20supervis%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20com%20um%20monitoramento%20adequado%20das%20fun%26%23xE7%3B%26%23xF5%3Bes%20hemodin%26%23xE2%3Bmicas.%3Cbr%3E%20%3Cbr%3E%20Efeitos%20nas%20caracter%26%23xED%3Bsticas%20do%20esperma%3A%20n%26%23xE3%3Bo%20houve%20efeitos%20clinicamente%20relevantes%20nas%20caracter%26%23xED%3Bsticas%20do%20esperma%20(ver%20ADVERT%26%23xCA%3BNCIAS%20E%20PRECAU%26%23xC7%3B%26%23xD5%3BES).%3Cbr%3E%20%3Cbr%3E%20Estudos%20da%20tadalafila%20sobre%20a%20Vis%26%23xE3%3Bo%3A%20em%20um%20estudo%20para%20avaliar%20os%20efeitos%20da%20tadalafila%20sobre%20a%20vis%26%23xE3%3Bo%2C%20n%26%23xE3%3Bo%20foi%20detectada%20dificuldade%20de%20discrimina%26%23xE7%3B%26%23xE3%3Bo%20de%20cor%20(azul%2Fverde)%20usando%20o%20teste%20de%20colora%26%23xE7%3B%26%23xE3%3Bo%20de%20Farnsworth-Munsell%20100.%20Este%20achado%20%26%23xE9%3B%20consistente%20com%20a%20baixa%20afinidade%20da%20tadalafila%20pelo%20PDE6%20comparado%20ao%20PDE5%20(ver%20CARACTER%26%23xCD%3BSTICAS%20FARMACOL%26%23xD3%3BGICAS%2C%20Propriedades%20farmacodin%26%23xE2%3Bmicas).%20Al%26%23xE9%3Bm%20disso%2C%20n%26%23xE3%3Bo%20foram%20observados%20efeitos%20na%20acuidade%20visual%2C%20eletrorretinogramas%2C%20press%26%23xE3%3Bo%20intraocular%20ou%20pupilometria.%20Cruzando%20todos%20os%20estudos%20cl%26%23xED%3Bnicos%2C%20os%20registros%20de%20altera%26%23xE7%3B%26%23xF5%3Bes%20na%20vis%26%23xE3%3Bo%20de%20cor%20foram%20raros%20(%26lt%3B%200%2C1%25).%3Cbr%3E%20%3Cbr%3E%20Estudos%20em%20Espermatog%26%23xEA%3Bnese%3A%20tr%26%23xEA%3Bs%20estudos%20foram%20conduzidos%20em%20homens%20para%20avaliar%20o%20efeito%20potencial%20da%20tadalafila%2010%20mg%20(um%20estudo%20de%206%20meses)%20e%2020%20mg%20(um%20estudo%20de%206%20meses%20e%20um%20estudo%20de%209%20meses)%2C%20administrada%20diariamente%2C%20sobre%20a%20espermatog%26%23xEA%3Bnese.%20N%26%23xE3%3Bo%20houve%20efeitos%20adversos%20sobre%20a%20morfologia%20ou%20motilidade%20do%20espermatozoide%20em%20qualquer%20dos%20tr%26%23xEA%3Bs%20estudos.%20No%20estudo%20de%206%20meses%20na%20dose%20di%26%23xE1%3Bria%20de%2010%20mg%20de%20tadalafila%20e%20no%20estudo%20de%209%20meses%20na%20dose%20di%26%23xE1%3Bria%20de%2020%20mg%20de%20tadalafila%2C%20os%20resultados%20mostraram%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20esperm%26%23xE1%3Btica%20m%26%23xE9%3Bdia%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20placebo.%20Este%20efeito%20n%26%23xE3%3Bo%20foi%20visto%20no%20estudo%20de%2020%20mg%20de%20tadalafila%20administrada%20por%206%20meses.%20No%20estudo%20de%209%20meses%2C%20a%20diminui%26%23xE7%3B%26%23xE3%3Bo%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20esperm%26%23xE1%3Btica%20foi%20associada%20%26%23xE0%3B%20uma%20frequ%26%23xEA%3Bncia%20ejaculat%26%23xF3%3Bria%20mais%20alta.%20A%20frequ%26%23xEA%3Bncia%20de%20ejacula%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20avaliada%20nos%20estudos%20de%206%20meses.%20Al%26%23xE9%3Bm%20disso%2C%20n%26%23xE3%3Bo%20houve%20efeito%20adverso%20sobre%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdias%20dos%20horm%26%23xF4%3Bnios%20reprodutivos%20(testosterona%2C%20horm%26%23xF4%3Bnio%20luteinizante%20ou%20horm%26%23xF4%3Bnio%20fol%26%23xED%3Bculoestimulante)%20com%20ambas%20as%20doses%20de%2010%20mg%20ou%2020%20mg%20de%20tadalafila%20comparadas%20ao%20placebo.%3Cbr%3E%20______________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20Descri%26%23xE7%3B%26%23xE3%3Bo%3A%20tadalafila%2C%20um%20tratamento%20oral%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20%26%23xE9%3B%20um%20inibidor%20revers%26%23xED%3Bvel%2C%20potente%20e%20seletivo%20da%20guanosina%20monofosfato%20c%26%23xED%3Bclica%20(GMPc)%20%26%23x2013%3B%20fosfodiesterase%20espec%26%23xED%3Bfica%20tipo%205%20(PDE5).%20A%20tadalafila%20tem%20f%26%23xF3%3Brmula%20emp%26%23xED%3Brica%20C22H19N3O4%20representando%20um%20peso%20molecular%20de%20389%2C41.%20O%20nome%20qu%26%23xED%3Bmico%20%26%23xE9%3Bpirazino%5B1%26%23x92%3B%2C2%26%23x92%3B%3A1%2C6%5Dpirido%5B3%2C4-b%5Dindol-1%2C4-diona%2C6-(1%2C3-benzodioxol-5-il)-2%2C3%2C6%2C7%2C12%2C12a-hexahidro-2-metil-%2C(6R%2C12aR).%20%26%23xC9%3B%20um%20s%26%23xF3%3Blido%20cristalino%20praticamente%20insol%26%23xFA%3Bvel%20em%20%26%23xE1%3Bgua%20e%20muito%20pouco%20sol%26%23xFA%3Bvel%20em%20etanol.%3Cbr%3E%20%3Cbr%3E%20Propriedades%20Farmacodin%26%23xE2%3Bmicas%3A%20Quando%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual%20causa%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20local%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE5%20pela%20tadalafila%20produz%20n%26%23xED%3Bveis%20elevados%20de%20GMPc%20no%20corpo%20cavernoso.%20Isso%20resulta%20no%20relaxamento%20da%20musculatura%20lisa%20e%20na%20entrada%20de%20sangue%20nos%20tecidos%20penianos%2C%20produzindo%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20A%20tadalafila%20n%26%23xE3%3Bo%20tem%20efeito%20na%20aus%26%23xEA%3Bncia%20de%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%3Cbr%3E%20Estudos%20in%20vitro%20mostraram%20que%20tadalafila%20%26%23xE9%3B%20um%20inibidor%20seletivo%20da%20PDE5%2C%20encontrada%20na%20musculatura%20lisa%20do%20corpo%20cavernoso%2C%20pr%26%23xF3%3Bstata%20e%20bexiga%2C%20bem%20como%20em%20musculatura%20lisa%20vascular%20e%20visceral%2C%20musculoesquel%26%23xE9%3Btico%2C%20plaquetas%2C%20rins%2C%20pulm%26%23xF5%3Bes%2C%20cerebelo%20e%20p%26%23xE2%3Bncreas.%20O%20efeito%20da%20tadalafila%20%26%23xE9%3B%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20outras%20fosfodiesterases.%20A%20tadalafila%20%26%23xE9%3B%20mais%20que%2010.000%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE1%2C%20PDE2%2C%20PDE4%20e%20PDE7%2C%20enzimas%20que%20s%26%23xE3%3Bo%20encontradas%20no%20cora%26%23xE7%3B%26%23xE3%3Bo%2C%20c%26%23xE9%3Brebro%2C%20vasos%20sangu%26%23xED%3Bneos%2C%20f%26%23xED%3Bgado%2C%20leuc%26%23xF3%3Bcitos%2C%20musculoesquel%26%23xE9%3Btico%20e%20outros%20%26%23xF3%3Brg%26%23xE3%3Bos.%20A%20tadalafila%20%26%23xE9%3B%20mais%20que%2010.000%20vezes%20mais%20potente%20para%20PDE5%20que%20para%20PDE3%2C%20uma%20enzima%20encontrada%20no%20cora%26%23xE7%3B%26%23xE3%3Bo%20e%20vasos%20sangu%26%23xED%3Bneos.%20Esta%20seletividade%20para%20a%20PDE5%20sobre%20PDE3%20%26%23xE9%3B%20importante%20porque%20PDE3%20%26%23xE9%3B%20uma%20enzima%20envolvida%20na%20contratilidade%20card%26%23xED%3Baca.%20Adicionalmente%2C%20a%20tadalafila%20%26%23xE9%3B%20aproximadamente%20700%20vezes%20mais%20potente%20para%20PDE5%20que%20para%20PDE6%2C%20uma%20enzima%20encontrada%20na%20retina%20e%20que%20%26%23xE9%3B%20respons%26%23xE1%3Bvel%20pela%20fototransdu%26%23xE7%3B%26%23xE3%3Bo.%20A%20tadalafila%20%26%23xE9%3B%20tamb%26%23xE9%3Bm%20mais%20que%209.000%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE%208%2C%209%2C%20e%2010%3B%20e%2014%20vezes%20mais%20potente%20sobre%20a%20PDE5%20que%20sobre%20a%20PDE11.%20A%20distribui%26%23xE7%3B%26%23xE3%3Bo%20nos%20tecidos%20e%20os%20efeitos%20fisiol%26%23xF3%3Bgicos%20da%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE8%20at%26%23xE9%3B%20PDE11%20n%26%23xE3%3Bo%20foram%20esclarecidos.%3Cbr%3E%20%3Cbr%3E%20Propriedades%20Farmacocin%26%23xE9%3Bticas%3A%3Cbr%3E%20Absor%26%23xE7%3B%26%23xE3%3Bo%3A%20a%20tadalafila%20%26%23xE9%3B%20rapidamente%20absorvida%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%20e%20a%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20observada%20(Cm%26%23xE1%3Bx)%20%26%23xE9%3B%20atingida%20num%20tempo%20m%26%23xE9%3Bdio%20de%202%20horas%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo.%20A%20biodisponibilidade%20absoluta%20da%20tadalafila%20ap%26%23xF3%3Bs%20dose%20oral%20n%26%23xE3%3Bo%20foi%20determinada.%3Cbr%3E%20A%20velocidade%20e%20extens%26%23xE3%3Bo%20da%20absor%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%20n%26%23xE3%3Bo%20s%26%23xE3%3Bo%20influenciadas%20pela%20alimenta%26%23xE7%3B%26%23xE3%3Bo%2C%20portanto%20tadalafila%20pode%20ser%20tomada%20com%20ou%20sem%20alimento.%20O%20per%26%23xED%3Bodo%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20(manh%26%23xE3%3B%20versus%20noite)%20n%26%23xE3%3Bo%20teve%20efeitos%20clinicamente%20relevantes%20sobre%20a%20velocidade%20e%20extens%26%23xE3%3Bo%20da%20absor%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20%3Cbr%3E%20Distribui%26%23xE7%3B%26%23xE3%3Bo%3A%20o%20volume%20de%20distribui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdio%20%26%23xE9%3B%20de%20aproximadamente%2063%20litros%2C%20indicando%20que%20tadalafila%20%26%23xE9%3B%20distribu%26%23xED%3Bda%20nos%20tecidos.%20Em%20concentra%26%23xE7%3B%26%23xF5%3Bes%20terap%26%23xEA%3Buticas%2C%2094%25%20da%20tadalafila%20est%26%23xE1%3B%20ligada%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas.%20Menos%20de%200%2C0005%25%20da%20dose%20administrada%20aparece%20no%20s%26%23xEA%3Bmen%20de%20indiv%26%23xED%3Bduos%20sadios.%3Cbr%3E%20%3Cbr%3E%20Metabolismo%3A%20a%20tadalafila%20%26%23xE9%3B%20predominantemente%20metabolizada%20pelo%20citocromo%20P450%20(CYP)%20isoforma%203A4.%20O%20maior%20metab%26%23xF3%3Blito%20circulante%20%26%23xE9%3B%20a%20glucuronida%20metilcatecol.%20Este%20metab%26%23xF3%3Blito%20%26%23xE9%3B%20pelo%20menos%2013.000%20vezes%20menos%20potente%20que%20a%20tadalafila%20para%20PDE5.%20Consequentemente%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20esperado%20que%20seja%20clinicamente%20ativo%20nas%20concentra%26%23xE7%3B%26%23xF5%3Bes%20observadas%20dos%20metab%26%23xF3%3Blitos.%3Cbr%3E%20%3Cbr%3E%20Elimina%26%23xE7%3B%26%23xE3%3Bo%3A%20o%20clearance%20oral%20m%26%23xE9%3Bdio%20para%20a%20tadalafila%20%26%23xE9%3B%202%2C5%20L%2Fh%2C%20e%20a%20meia-vida%20m%26%23xE9%3Bdia%20%26%23xE9%3B%20de%2017%2C5%20horas%20em%20indiv%26%23xED%3Bduos%20sadios.%20A%20tadalafila%20%26%23xE9%3B%20excretada%20predominantemente%20como%20metab%26%23xF3%3Blitos%2C%20principalmente%20nas%20fezes%20(aproximadamente%2061%25%20da%20dose)%20e%2C%20em%20menor%20extens%26%23xE3%3Bo%2C%20na%20urina%20(aproximadamente%2036%25%20da%20dose).%3Cbr%3E%20Os%20par%26%23xE2%3Bmetros%20farmacocin%26%23xE9%3Bticos%20da%20tadalafila%20em%20indiv%26%23xED%3Bduos%20sadios%20s%26%23xE3%3Bo%20lineares%20com%20respeito%20ao%20tempo%20e%20%26%23xE0%3B%20dose.%20Num%20intervalo%20de%20dose%20de%202%2C5%20a%2020%20mg%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(%26%23xE1%3Brea%20sob%20a%20curva%20%26%23x2013%3B%20AUC)%20aumenta%20proporcionalmente%20com%20a%20dose.%20As%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20no%20estado%20de%20equil%26%23xED%3Bbrio%20s%26%23xE3%3Bo%20alcan%26%23xE7%3Badas%20dentro%20de%205%20dias%20de%20dose%20%26%23xFA%3Bnica%20di%26%23xE1%3Bria.%20A%20farmacocin%26%23xE9%3Btica%20determinada%20em%20uma%20popula%26%23xE7%3B%26%23xE3%3Bo%20de%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20%26%23xE9%3B%20similar%20%26%23xE0%3B%20farmacocin%26%23xE9%3Btica%20em%20indiv%26%23xED%3Bduos%20sem%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20%3Cbr%3E%20Farmacocin%26%23xE9%3Btica%20em%20popula%26%23xE7%3B%26%23xF5%3Bes%20especiais%3A%3Cbr%3E%20Idosos%3A%20indiv%26%23xED%3Bduos%20idosos%20sadios%20(65%20anos%20ou%20mais)%20tiveram%20um%20clearance%20oral%20menor%20de%20tadalafila%2C%20resultando%20em%20uma%20exposi%26%23xE7%3B%26%23xE3%3Bo%20(AUC)%2025%25%20maior%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20a%20indiv%26%23xED%3Bduos%20sadios%20de%20idade%20entre%2019%20e%2045%20anos.%20Este%20efeito%20da%20idade%20n%26%23xE3%3Bo%20%26%23xE9%3B%20clinicamente%20significativo%20e%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20de%20dose.%3Cbr%3E%20%3Cbr%3E%20Pedi%26%23xE1%3Btricos%3A%20a%20tadalafila%20n%26%23xE3%3Bo%20foi%20avaliada%20em%20indiv%26%23xED%3Bduos%20com%20menos%20de%2018%20anos.%3Cbr%3E%20%3Cbr%3E%20Insufici%26%23xEA%3Bncia%20Hep%26%23xE1%3Btica%3A%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%20(Child-Pugh%20Classe%20A%20e%20B)%20%26%23xE9%3B%20compar%26%23xE1%3Bvel%20%26%23xE0%3B%20exposi%26%23xE7%3B%26%23xE3%3Bo%20em%20indiv%26%23xED%3Bduos%20sadios.%20N%26%23xE3%3Bo%20existem%20dados%20dispon%26%23xED%3Bveis%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(Child-Pugh%20Classe%20C).%3Cbr%3E%20%3Cbr%3E%20Insufici%26%23xEA%3Bncia%20Renal%3A%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20renal%2C%20incluindo%20aqueles%20em%20hemodi%26%23xE1%3Blise%2C%20a%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20foi%20maior%20que%20em%20indiv%26%23xED%3Bduos%20sadios.%3Cbr%3E%20%3Cbr%3E%20Pacientes%20com%20Diabetes%3A%20A%20exposi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20tadalafila%20(AUC)%20em%20pacientes%20com%20diabetes%20foi%20aproximadamente%2019%25%20menor%20que%20o%20valor%20de%20AUC%20para%20indiv%26%23xED%3Bduos%20sadios.%20Esta%20diferen%26%23xE7%3Ba%20na%20exposi%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20exige%20um%20ajuste%20de%20dose.%3Cbr%3E%20%3Cbr%3E%20Estudos%20da%20tadalafila%20na%20Frequ%26%23xEA%3Bncia%20Card%26%23xED%3Baca%20e%20Press%26%23xE3%3Bo%20Arterial%3A%20tadalafila%20administrada%20a%20indiv%26%23xED%3Bduos%20sadios%20n%26%23xE3%3Bo%20produziu%20diferen%26%23xE7%3Ba%20significativa%2C%20comparando-se%20ao%20grupo%20placebo%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20sist%26%23xF3%3Blica%20e%20diast%26%23xF3%3Blica%20em%20dec%26%23xFA%3Bbito%20horizontal%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20de%201%2C6%2F0%2C8%20mmHg%2C%20respectivamente)%2C%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20sist%26%23xF3%3Blica%20e%20diast%26%23xF3%3Blica%20em%20p%26%23xE9%3B%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE1%3Bxima%20m%26%23xE9%3Bdia%20de%200%2C2%2F4%2C6%20mmHg%2C%20respectivamente)%20e%20n%26%23xE3%3Bo%20houve%20altera%26%23xE7%3B%26%23xE3%3Bo%20significante%20na%20frequ%26%23xEA%3Bncia%20card%26%23xED%3Baca.%20Efeitos%20maiores%20foram%20relatados%20entre%20indiv%26%23xED%3Bduos%20recebendo%20nitratos%20concomitantemente%20(ver%20CONTRAINDICA%26%23xC7%3B%26%23xD5%3BES).%3Cbr%3E%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xE3%3Bo%20com%20Nitratos%3A%20um%20estudo%20foi%20realizado%20para%20avaliar%20o%20n%26%23xED%3Bvel%20de%20intera%26%23xE7%3B%26%23xE3%3Bo%20entre%20nitratos%20e%20a%20tadalafila.%20O%20objetivo%20do%20estudo%20foi%20determinar%20qual%20o%20per%26%23xED%3Bodo%2C%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%2C%20n%26%23xE3%3Bo%20iria%20ocorrer%20uma%20intera%26%23xE7%3B%26%23xE3%3Bo%20aparente%20na%20press%26%23xE3%3Bo%20arterial.%20Os%20pacientes%20envolvidos%20no%20estudo%20(incluindo%20pacientes%20diab%26%23xE9%3Bticos%20e%2F%20ou%20hipertensos%20com%20a%20press%26%23xE3%3Bo%20arterial%20controlada)%20receberam%20diariamente%20doses%20de%2020%20mg%20de%20tadalafila%20ou%20placebo%20durante%207%20dias%2C%20quando%20ent%26%23xE3%3Bo%20receberam%20uma%20%26%23xFA%3Bnica%20dose%20de%200%2C4%20mg%20de%20nitroglicerina%20sublingual%20em%20per%26%23xED%3Bodos%20pr%26%23xE9%3B-%20determinados%20ap%26%23xF3%3Bs%20a%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila.%20O%20resultado%20deste%20estudo%20demonstrou%20que%20n%26%23xE3%3Bo%20foi%20detectada%20intera%26%23xE7%3B%26%23xE3%3Bo%20ap%26%23xF3%3Bs%2048%20horas%20da%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila.%3Cbr%3E%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20tadalafila%20com%20nitratos%20%26%23xE9%3B%20contraindicada.%20Quando%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nitratos%20for%20extremamente%20necess%26%23xE1%3Bria%20em%20paciente%20que%20tomaram%20tadalafila%2C%20deve%20ser%20considerado%20o%20intervalo%20de%20pelo%20menos%2048%20horas%20ap%26%23xF3%3Bs%20a%20%26%23xFA%3Bltima%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20para%20administrar%20nitratos.%20Nestas%20circunst%26%23xE2%3Bncias%2C%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20nitratos%20deve%20ser%20realizada%20sob%20estreita%20supervis%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20com%20um%20monitoramento%20adequado%20das%20fun%26%23xE7%3B%26%23xF5%3Bes%20hemodin%26%23xE2%3Bmicas.%3Cbr%3E%20%3Cbr%3E%20Efeitos%20nas%20Caracter%26%23xED%3Bsticas%20do%20Esperma%3A%20n%26%23xE3%3Bo%20houve%20efeitos%20clinicamente%20relevantes%20nas%20caracter%26%23xED%3Bsticas%20do%20esperma%20(ver%20ADVERT%26%23xCA%3BNCIAS%20E%20PRECAU%26%23xC7%3B%26%23xD5%3BES).%3Cbr%3E%20%3Cbr%3E%20Estudos%20da%20tadalafila%20Sobre%20a%20Vis%26%23xE3%3Bo%3A%20em%20um%20estudo%20para%20avaliar%20os%20efeitos%20da%20tadalafila%20sobre%20a%20vis%26%23xE3%3Bo%2C%20n%26%23xE3%3Bo%20foi%20detectada%20dificuldade%20de%20discrimina%26%23xE7%3B%26%23xE3%3Bo%20de%20cor%20(azul%2Fverde)%20usando%20o%20teste%20de%20colora%26%23xE7%3B%26%23xE3%3Bo%20de%20Farnsworth-Munsell100.%20Este%20achado%20%26%23xE9%3B%20consistente%20com%20a%20baixa%20afinidade%20da%20tadalafila%20pelo%20PDE6%20comparado%20ao%20PDE5%20(ver%20CARACTER%26%23xCD%3BSTICAS%20FARMACOL%26%23xD3%3BGICAS%2C%20Propriedades%20farmacodin%26%23xE2%3Bmicas).%20Al%26%23xE9%3Bm%20disso%2C%20n%26%23xE3%3Bo%20foram%20observados%20efeitos%20na%20acuidade%20visual%2C%20eletrorretinogramas%2C%20press%26%23xE3%3Bo%20intraocular%20ou%20pupilometria.%20Cruzando%20todos%20os%20estudos%20cl%26%23xED%3Bnicos%2C%20os%20registros%20de%20altera%26%23xE7%3B%26%23xF5%3Bes%20na%20vis%26%23xE3%3Bo%20de%20cor%20foram%20raros%20(%26lt%3B%200%2C1%25).%3Cbr%3E%20%3Cbr%3E%20Estudos%20em%20Espermatog%26%23xEA%3Bnese%3A%20tr%26%23xEA%3Bs%20estudos%20foram%20conduzidos%20em%20homens%20para%20avaliar%20o%20efeito%20potencial%20de%20tadalafila%2010%20mg%20(um%20estudo%20de%206%20meses)%20e%2020%20mg%20(um%20estudo%20de%206%20meses%20e%20um%20estudo%20de%209%20meses)%2C%20administrada%20diariamente%2C%20sobre%20a%20espermatog%26%23xEA%3Bnese.%20N%26%23xE3%3Bo%20houve%20efeitos%20adversos%20sobre%20a%20morfologia%20ou%20motilidade%20do%20espermatozoide%20em%20qualquer%20dos%20tr%26%23xEA%3Bs%20estudos.%20No%20estudo%20de%206%20meses%20na%20dose%20di%26%23xE1%3Bria%20de%2010%20mg%20de%20tadalafila%20e%20no%20estudo%20de%209%20meses%20na%20dose%20di%26%23xE1%3Bria%20de%2020%20mg%20de%20tadalafila%2C%20os%20resultados%20mostraram%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20esperm%26%23xE1%3Btica%20m%26%23xE9%3Bdia%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20placebo%2C%20embora%20estas%20diferen%26%23xE7%3Bas%20n%26%23xE3%3Bo%20sejam%20clinicamente%20significantes.%20Este%20efeito%20n%26%23xE3%3Bo%20foi%20visto%20no%20estudo%20de%2020%20mg%20de%20tadalafila%20administrada%20por%206%20meses.%20No%20estudo%20de%209%20meses%2C%20a%20diminui%26%23xE7%3B%26%23xE3%3Bo%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20esperm%26%23xE1%3Btica%20foi%20associada%20%26%23xE0%3B%20uma%20frequ%26%23xEA%3Bncia%20ejaculat%26%23xF3%3Bria%20mais%20alta.%20A%20frequ%26%23xEA%3Bncia%20de%20ejacula%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20avaliada%20nos%20estudos%20de%206%20meses.%20Al%26%23xE9%3Bm%20disso%2C%20n%26%23xE3%3Bo%20houve%20efeito%20adverso%20sobre%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdias%20dos%20horm%26%23xF4%3Bnios%20reprodutivos%20(testosterona%2C%20horm%26%23xF4%3Bnio%20luteinizante%20ou%20horm%26%23xF4%3Bnio%20fol%26%23xED%3Bculo-%20estimulante)%20com%20ambas%20as%20doses%20de%2010%20mg%20ou%2020%20mg%20de%20tadalafila%20comparadas%20ao%20placebo.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EResultados%20de%20eficacia%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20Efeitos%20da%20tadalafila%20sobre%20a%20Fun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20a%20tadalafila%20administrada%20na%20dose%20de%202%2C5%20mg%2C%205%20mg%20e%2010%20mg%2C%20uma%20vez%20ao%20dia%2C%20foi%20avaliada%20em%203%20estudos%20cl%26%23xED%3Bnicos%20envolvendo%20853%20pacientes%20de%20v%26%23xE1%3Brias%20faixas%20et%26%23xE1%3Brias%20(de%2021%20a%2082%20anos)%20e%20etnias%2C%20com%20v%26%23xE1%3Brios%20graus%20de%20etiologia%20e%20de%20gravidade%20de%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(leve%2C%20moderado%20e%20grave).%20Nos%20dois%20principais%20estudos%20de%20efic%26%23xE1%3Bcia%20na%20popula%26%23xE7%3B%26%23xE3%3Bo%20geral%2C%2076%20e%2085%25%20dos%20pacientes%20relataram%20que%20a%20tadalafila%20administrada%20uma%20vez%20ao%20dia%20melhorou%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%2C%20comparado%20a%2029%20e%2030%25%20dos%20pacientes%20do%20grupo%20placebo.%20Al%26%23xE9%3Bm%20disso%2C%20os%20pacientes%20de%20todas%20as%20categorias%20de%20gravidade%20de%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20relataram%20melhora%20na%20ere%26%23xE7%3B%26%23xE3%3Bo%2C%20enquanto%20tomavam%20tadalafila%20uma%20vez%20ao%20dia.%20Nos%20estudos%20principais%20de%20efic%26%23xE1%3Bcia%2062%20e%2069%25%20da%20popula%26%23xE7%3B%26%23xE3%3Bo%20estudada%20tratada%20com%20tadalafila%205%20mg%20obtiveram%20sucesso%20nas%20tentativas%20de%20ter%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20comparado%20a%2034%20e%2039%25%20do%20grupo%20placebo.%20A%20dose%20de%205%20mg%20de%20tadalafila%20melhora%20significativamente%20a%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20por%20um%20per%26%23xED%3Bodo%20superior%20a%2024%20horas%20entre%20as%20doses.%3Cbr%3E%20%3Cbr%3E%20Efeitos%20da%20tadalafila%20sobre%20sinais%20e%20sintomas%20da%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%3A%20A%20tadalafila%20administrada%20na%20dose%20de%205%20mg%2C%20uma%20vez%20ao%20dia%2C%20foi%20avaliada%20em%202%20estudos%20cl%26%23xED%3Bnicos%20envolvendo%20749%20pacientes%20com%20idade%20acima%20de%2045%20anos%20(40%25%20acima%20de%2065%20anos)%20portadores%20de%20sinais%20e%20sintomas%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%2C%20e%201%20estudo%20cl%26%23xED%3Bnico%20envolvendo%20408%20pacientes%20com%20sintomas%20de%20HPB%20e%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20associada.%20O%20objetivo%20prim%26%23xE1%3Brio%20nos%203%20estudos%20foi%20a%20melhora%20do%20%26%23xED%3Bndice%20Internacional%20de%20Sintomas%20da%20Pr%26%23xF3%3Bstata%20(IPSS%2C%20na%20sigla%20em%20ingl%26%23xEA%3Bs)%20ap%26%23xF3%3Bs%2012%20semanas%20de%20tratamento%2C%20sendo%20demonstrada%20melhora%20estatisticamente%20significativa%20(p%26lt%3B0%2C005)%20do%20uso%20de%20tadalafila%205%20mg%20comparado%20com%20placebo%20nos%20sintomas%20de%20HPB%20ao%20fim%20deste%20per%26%23xED%3Bodo.%3Cbr%3E%20%3Cbr%3E%20Efic%26%23xE1%3Bcia%20na%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20de%20Pacientes%20com%20Diabetes%20mellitus%3A%20A%20tadalafila%20administrada%20uma%20vez%20ao%20diamostrou-se%20eficaz%20no%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20em%20pacientes%20com%20diabetes.%20Pacientes%20com%20diabetes%20foram%20inclu%26%23xED%3Bdos%20em%20todos%20os%207%20estudos%20de%20efic%26%23xE1%3Bcia%20prim%26%23xE1%3Bria%20com%20popula%26%23xE7%3B%26%23xE3%3Bo%20geral%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(N%20%3D%20235)%20e%20um%20estudo%20que%20avaliou%20especificamente%20tadalafila%20apenas%20em%20pacientes%20diab%26%23xE9%3Bticos%20(Tipo%201%20ou%20Tipo%202)%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(N%20%3D%20216).%20Um%20estudo%20randomizado%2C%20multic%26%23xEA%3Bntrico%2C%20duplo-cego%2C%20placebo-controlado%20e%20de%20bra%26%23xE7%3Bo%20paralelo%20demonstrou%20melhora%20cl%26%23xED%3Bnica%20consistente%20e%20estatisticamente%20significativa%20na%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20de%20pacientes%20diab%26%23xE9%3Bticos%20com%20o%20uso%20de%20tadalafila%20administrada%20uma%20vez%20ao%20dia.%3Cbr%3E%20______________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20Desenho%20do%20Estudo%3A%20a%20efic%26%23xE1%3Bcia%20e%20a%20seguran%26%23xE7%3Ba%20da%20tadalafila%20no%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20foram%20avaliadas%20em%2022%20estudos%20cl%26%23xED%3Bnicos%20de%20at%26%23xE9%3B%2024%20semanas%20de%20dura%26%23xE7%3B%26%23xE3%3Bo.%20Os%20estudos%20envolveram%20mais%20de%204.000%20pacientes%2C%20tendo%20sido%20estudadas%20as%20dosagens%20de%202%20a%20100%20mg%2C%20tomadas%20quando%20necess%26%23xE1%3Brio%2C%20at%26%23xE9%3B%20uma%20vez%20ao%20dia.%20A%20tadalafila%20mostrou%20ser%20eficaz%20na%20melhora%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20em%20homens%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(DE).%3Cbr%3E%20V%26%23xE1%3Brios%20instrumentos%20de%20avalia%26%23xE7%3B%26%23xE3%3Bo%20foram%20usados%20para%20estudar%20o%20efeito%20da%20tadalafila%20na%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%20Quest%26%23xF5%3Bes%20de%20Avalia%26%23xE7%3B%26%23xE3%3Bo%20Global%20(QAG)%20foram%20feitas%20para%20determinar%20se%20o%20tratamento%20melhorou%20as%20ere%26%23xE7%3B%26%23xF5%3Bes%20dos%20pacientes.%20Durante%20os%20estudos%20cl%26%23xED%3Bnicos%2C%20os%20pacientes%20e%20suas%20parceiras%20completaram%20di%26%23xE1%3Brios%20de%20Perfil%20de%20Encontro%20Sexual%20(PES)%2C%20avaliando%20a%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20a%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20de%20cada%20tentativa%20sexual.%20O%20%26%23xCD%3Bndice%20Internacional%20de%20Fun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20(IIFE)%20tamb%26%23xE9%3Bm%20foi%20completado%20pelos%20pacientes.%20O%20IIFE%20fornece%20medidas%20globais%20de%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20bem%20como%20a%20gravidade%20da%20DE.%3Cbr%3E%20%3Cbr%3E%20Efeitos%20da%20tadalafila%20Sobre%20a%20Fun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20em%20todos%20os%20estudos%2C%20a%20tadalafila%20demonstrou%20melhora%20consistente%20e%20estatisticamente%20significante%20comparada%20ao%20placebo%2C%20em%20todos%20os%20objetivos%20prim%26%23xE1%3Brios%20e%20secund%26%23xE1%3Brios%20avaliados.%20O%20efeito%20do%20tratamento%20n%26%23xE3%3Bo%20diminuiu%20com%20o%20tempo.%20A%20tadalafila%2C%20nas%20doses%20de%202%20a%20100%20mg%2C%20foi%20avaliada%20em%2016%20estudos%20cl%26%23xED%3Bnicos%20envolvendo%203.250%20pacientes%2C%20incluindo%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20de%20v%26%23xE1%3Brios%20n%26%23xED%3Bveis%20de%20gravidade%20(leve%2C%20moderada%20e%20grave)%2C%20etiologias%20(incluindo%20pacientes%20com%20diabetes)%2C%20idades%20(21%20a%2086%20anos)%2C%20etnias%20e%20dura%26%23xE7%3B%26%23xE3%3Bo%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%20Nos%20estudos%20de%20efic%26%23xE1%3Bcia%20prim%26%23xE1%3Bria%20de%20popula%26%23xE7%3B%26%23xF5%3Bes%20em%20geral%2C%2081%25%20dos%20pacientes%20relataram%20que%20tadalafila%20melhorou%20suas%20ere%26%23xE7%3B%26%23xF5%3Bes.%20Tamb%26%23xE9%3Bm%2C%20pacientes%20com%20DE%2C%20em%20todas%20as%20categorias%20de%20gravidade%2C%20relataram%20ere%26%23xE7%3B%26%23xF5%3Bes%20melhores%20enquanto%20tomavam%20tadalafila%20(86%25%2C%2083%25e%2072%25%20para%20leve%2C%20moderada%20e%20grave%2C%20respectivamente).%3Cbr%3E%20A%20tadalafila%20mostrou%20melhora%20estatisticamente%20significante%20na%20capacidade%20dos%20pacientes%20em%20obter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20suficiente%20para%20a%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20e%20de%20manter%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20para%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20satisfat%26%23xF3%3Bria%2C%20medida%20pelos%20di%26%23xE1%3Brios%20de%20PES.%20Nos%20estudos%20de%20efic%26%23xE1%3Bcia%20prim%26%23xE1%3Bria%2C%2075%25%20das%20tentativas%20de%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20foram%20bem%20sucedidas%20em%20pacientes%20tratados%20com%20tadalafila.%3Cbr%3E%20A%20tadalafila%20tamb%26%23xE9%3Bm%20demonstrou%20melhora%20estatisticamente%20significante%20na%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20medida%20pelo%20Dom%26%23xED%3Bnio%20de%20Fun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20do%20IIFE.%20Adicionalmente%2C%20nos%20estudos%20de%20efic%26%23xE1%3Bcia%20prim%26%23xE1%3Bria%2C%20na%20dosagem%20de%2020%20mg%2C%20aproximadamente%2060%25%20dos%20pacientes%20tratados%20com%20tadalafila%20atingiram%20a%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20normal%20durante%20o%20tratamento.%3Cbr%3E%20%3Cbr%3E%20Per%26%23xED%3Bodo%20de%20Resposta%3A%20dois%20estudos%20cl%26%23xED%3Bnicos%20foram%20conduzidos%20em%20571%20pacientes%20em%20ambiente%20domiciliar%2C%20para%20definir%20o%20per%26%23xED%3Bodo%20de%20resposta%20%26%23xE0%3B%20tadalafila.%20A%20tadalafila%20demonstrou%20melhora%20estatisticamente%20significante%20na%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20na%20capacidade%20de%20ter%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20satisfat%26%23xF3%3Bria%20at%26%23xE9%3B%2036%20horas%20ap%26%23xF3%3Bs%20a%20dose%2C%20assim%20como%20na%20capacidade%20dos%20pacientes%20de%20atingir%20e%20manter%20ere%26%23xE7%3B%26%23xF5%3Bes%20para%20rela%26%23xE7%3B%26%23xF5%3Bes%20satisfat%26%23xF3%3Brias%2C%20se%20comparados%20ao%20grupo%20placebo%2C%20a%20partir%20de%2030%20minutos%20ap%26%23xF3%3Bs%20a%20dose.%3Cbr%3E%20%3Cbr%3E%20Confian%26%23xE7%3Ba%20do%20Paciente%20e%20Satisfa%26%23xE7%3B%26%23xE3%3Bo%20Sexual%3A%20o%20IIFE%20tamb%26%23xE9%3Bm%20mede%20a%20confian%26%23xE7%3Ba%20que%20os%20pacientes%20podem%20atingir%20e%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20suficiente%20para%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20A%20tadalafila%20melhorou%20a%20confian%26%23xE7%3Ba%20do%20paciente%20de%20modo%20estatisticamente%20significante.%20A%20an%26%23xE1%3Blise%20dos%20dom%26%23xED%3Bnios%20de%20Satisfa%26%23xE7%3B%26%23xE3%3Bo%20na%20Rela%26%23xE7%3B%26%23xE3%3Bo%20Sexual%20e%20Satisfa%26%23xE7%3B%26%23xE3%3Bo%20Global%20do%20IIFE%20mostrou%20que%20o%20tratamento%20com%20a%20tadalafila%20resulta%20em%20aumento%20estatisticamente%20significante%20da%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20medida%20por%20ambos%20os%20dom%26%23xED%3Bnios.%20Adicionalmente%2C%20tadalafila%20melhorou%20a%20propor%26%23xE7%3B%26%23xE3%3Bo%20dos%20encontros%20sexuais%20que%20foram%20satisfat%26%23xF3%3Brios%20para%20o%20paciente%20e%20sua%20parceira.%3Cbr%3E%20%3Cbr%3E%20Efic%26%23xE1%3Bcia%20na%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20de%20Pacientes%20com%20diabetes%20mellitus%3A%20a%20tadalafila%20%26%23xE9%3B%20eficaz%20no%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20em%20pacientes%20com%20diabetes.%20Pacientes%20com%20diabetes%20(N%3D%20451)%20foram%20inclu%26%23xED%3Bdos%20em%20todos%20os%20estudos%20de%20efic%26%23xE1%3Bcia%20prim%26%23xE1%3Bria%2C%20um%20dos%20quais%20avaliou%20especificamente%20a%20tadalafila%20apenas%20em%20pacientes%20diab%26%23xE9%3Bticos%20(Tipo%201%20ou%20Tipo%202)%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%20Tadalafila%20produziu%20melhora%20estatisticamente%20significante%20na%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20na%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20Nestes%20estudos%2C%2068%25%20dos%20pacientes%20com%20diabetes%20tratados%20com%20tadalafila%2C%20na%20dose%20de%2020%20mg%2C%20relataram%20ere%26%23xE7%3B%26%23xF5%3Bes%20melhores.%3Cbr%3E%20%3Cbr%3E%20Efic%26%23xE1%3Bcia%20na%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20de%20Pacientes%20que%20Sofreram%20Prostatectomia%20Radical%3A%20a%20tadalafila%20mostrou%20ser%20eficaz%20no%20tratamento%20de%20pacientes%20que%20desenvolveram%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20devido%20%26%23xE0%3B%20prostatectomia%20radical%20com%20preserva%26%23xE7%3B%26%23xE3%3Bo%20nervosa%20bilateral.%20Em%20um%20estudo%20randomizado%2C%20placebo-controlado%2C%20duplo-cego%2C%20paralelo%2C%20prospectivo%20nesta%20popula%26%23xE7%3B%26%23xE3%3Bo%20(N%3D%20303)%2C%20a%20tadalafila%20demonstrou%20uma%20melhora%20clinicamente%20significante%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20sendo%20que%2062%25%20dos%20pacientes%20relataram%20melhora%20das%20ere%26%23xE7%3B%26%23xF5%3Bes%20com%20o%20uso%20de%20tadalafila%2020%20mg.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EUsos%20em%20idosos%2C%20crian%26%23xE7%3Bas%20e%20em%20outros%20grupos%20de%20risco%3C%2Fh2%3E%0A%3Cp%3EInforma%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20dispon%26%23xED%3Bvel%20para%20esta%20bula.%3C%2Fp%3E%0A%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%3C%2Famp-ad%3E%0A%3Ch2%3EArmazenagem%3C%2Fh2%3E%0A%3Cp%3EConservar%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC).%3Cbr%3E%20O%20prazo%20de%20validade%20do%20produto%20nestas%20condi%26%23xE7%3B%26%23xF5%3Bes%20de%20armazenagem%20%26%23xE9%3B%20de%2024%20meses.%3Cbr%3E%20%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vide%20embalagem.%3Cbr%3E%20N%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido.%20Guarde-o%20em%20sua%20embalagem%20original.%3Cbr%3E%20%3Cbr%3E%20Aspecto%20f%26%23xED%3Bsico%3A%20tadalafila%20apresenta-se%20na%20forma%20de%20comprimido%20revestido%2C%20branco%20sem%20vinco.%3Cbr%3E%20%3Cbr%3E%20Antes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%3Cbr%3E%20Todo%20medicamento%20deve%20ser%20mantido%20fora%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EDizeres%20legais%3C%2Fh2%3E%0A%3Cp%3EVenda%20sob%20prescri%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica.%3Cbr%3E%20M.S.%3A%201.0043.1103%3Cbr%3E%20Farm.%20Resp.%3A%20Dra.%20S%26%23xF4%3Bnia%20Albano%20Badar%26%23xF3%3B%20%26%23x96%3B%20CRF-SP%2019.258%3Cbr%3E%20%3Cbr%3E%20Fabricado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Rod.%20Pres.%20Castelo%20Branco%2C%20km%2035%2C6%20%26%23x2013%3B%20Itapevi%20%26%23x96%3B%20SP%3Cbr%3E%20%3Cbr%3E%20Registrado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Av.%20Vereador%20Jos%26%23xE9%3B%20Diniz%2C%203.465%20%26%23x2013%3B%20S%26%23xE3%3Bo%20Paulo%20%26%23x2013%3B%20SP%3Cbr%3E%20CNPJ%3A%2061.190.096%2F0001-92%20%26%23x2013%3B%20Ind%26%23xFA%3Bstria%20Brasileira%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ETadalafila%20%26%23x2013%3B%20Bula%20para%20o%20paciente%3C%2Fh2%3E%0A%3Cp%3EComprimido%20revestido%3Cbr%3E%205%20mg%3Cbr%3E%20%3Cbr%3E%20FORMAS%20FARMAC%26%23xCA%3BUTICAS%20E%20APRESENTA%26%23xC7%3B%26%23xD5%3BES%20%20%3Cbr%3E%20Embalagem%20com%2030%20comprimidos%20contendo%205%20mg%20de%20tadalafila.%20%20%3Cbr%3E%20%3Cbr%3E%20EXCLUSIVAMENTE%20PARA%20ADMINISTRA%26%23xC7%3B%26%23xC3%3BO%20ORAL%20%20%3Cbr%3E%20USO%20ADULTO%20ACIMA%20DE%2018%20ANOS%20%20%3Cbr%3E%20%3Cbr%3E%20COMPOSI%26%23xC7%3B%26%23xC3%3BO%20%20%3Cbr%3E%20Cada%20comprimido%20cont%26%23xE9%3Bm%3A%20%20%3Cbr%3E%20tadalafila%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..5%20mg%3Cbr%3E%20excipientes%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B1%20comprimido%3Cbr%3E%20Excipientes%3A%20lactose%2C%20lactose%20monoidratada%2C%20hiprolose%2C%20laurilsulfato%20de%20s%26%23xF3%3Bdio%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20celulose%20microcristalina%2C%20di%26%23xF3%3Bxido%20de%20sil%26%23xED%3Bcio%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20hipromelose%2C%20triacetina%20e%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio.%3Cbr%3E%20%3Cbr%3E%201.%20PARA%20QUE%20ESTE%20MEDICAMENTO%20%26%23xC9%3B%20INDICADO%3F%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20indicado%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20indicado%20para%20o%20tratamento%20dos%20sinais%20e%20sintomas%20da%20hiperplasia%20prost%26%23xE1%3Btica%20benigna%20(HPB)%20em%20homens%20adultos%20incluindo%20aqueles%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20%3Cbr%3E%202.%20COMO%20ESTE%20MEDICAMENTO%20FUNCIONA%3F%20%3Cbr%3E%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3Cbr%3E%20Defini%26%23xE7%3B%26%23xE3%3Bo%3A%20quando%20existe%20um%20est%26%23xED%3Bmulo%20sexual%2C%20o%20p%26%23xEA%3Bnis%20se%20enche%20de%20sangue%20e%20o%20homem%20tem%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20Se%20o%20homem%20tiver%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(DE)%2C%20o%20p%26%23xEA%3Bnis%20n%26%23xE3%3Bo%20se%20enche%20de%20sangue%20de%20forma%20adequada%20e%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20%26%23xE9%3B%20suficiente%20para%20ocorrer%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20A%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20tamb%26%23xE9%3Bm%20chamada%20de%20impot%26%23xEA%3Bncia%20sexual%2C%20pode%20ter%20diversas%20causas.%20%26%23xC9%3B%20importante%20consultar%20um%20m%26%23xE9%3Bdico%20para%20descobrir%20a%20natureza%20desse%20problema.%20A%20tadalafila%20pode%20ajudar%20o%20homem%20com%20DE%20a%20obter%20e%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20quando%20estiver%20sexualmente%20excitado.%3Cbr%3E%20%3Cbr%3E%20A%26%23xE7%3B%26%23xE3%3Bo%20do%20medicamento%3A%20tadalafila%20%26%23xE9%3B%20um%20medicamento%20para%20o%20tratamento%20da%20dificuldade%20de%20obten%26%23xE7%3B%26%23xE3%3Bo%20e%2Fou%20manuten%26%23xE7%3B%26%23xE3%3Bo%20da%20ere%26%23xE7%3B%26%23xE3%3Bo%20do%20p%26%23xEA%3Bnis%20(disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil).%20Quando%20um%20homem%20%26%23xE9%3B%20sexualmente%20estimulado%2C%20a%20resposta%20f%26%23xED%3Bsica%20normal%20do%20seu%20corpo%20%26%23xE9%3B%20o%20aumento%20do%20fluxo%20sangu%26%23xED%3Bneo%20no%20p%26%23xEA%3Bnis.%20Isso%20resulta%20em%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20Este%20medicamento%20ajuda%20a%20aumentar%20o%20fluxo%20de%20sangue%20no%20p%26%23xEA%3Bnis%20e%20pode%20auxiliar%20homens%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20a%20obterem%20e%20manterem%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20satisfat%26%23xF3%3Bria%20para%20a%20atividade%20sexual.%20Uma%20vez%20completa%20a%20atividade%20sexual%2C%20o%20fluxo%20sangu%26%23xED%3Bneo%20do%20p%26%23xEA%3Bnis%20diminui%20e%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20termina.%20Para%20tadalafila%20funcionar%2C%20%26%23xE9%3B%20necess%26%23xE1%3Bria%20uma%20excita%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20O%20homem%20n%26%23xE3%3Bo%20ter%26%23xE1%3B%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20apenas%20por%20tomar%20um%20comprimido%20de%20tadalafila%2C%20sem%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%3Cbr%3E%20%3Cbr%3E%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%3Cbr%3E%20Defini%26%23xE7%3B%26%23xE3%3Bo%3A%20a%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20%26%23xE9%3B%20um%20aumento%20benigno%20da%20pr%26%23xF3%3Bstata%20que%20pode%20causar%20o%20estreitamento%20da%20uretra%20e%20dificuldade%20de%20mic%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20%3Cbr%3E%20A%26%23xE7%3B%26%23xE3%3Bo%20do%20Medicamento%3A%20tadalafila%20atua%20relaxando%20a%20musculatura%20da%20pr%26%23xF3%3Bstata%2C%20da%20bexiga%20e%20dos%20vasos%20sangu%26%23xED%3Bneos.%20O%20relaxamento%20da%20vasculatura%20resulta%20no%20aumento%20do%20suprimento%20de%20sangue%20para%20a%20pr%26%23xF3%3Bstata%20e%20bexiga%20e%20pode%20reduzir%20os%20sintomas%20da%20HPB.%20O%20relaxamento%20da%20pr%26%23xF3%3Bstata%20e%20da%20bexiga%20podem%20complementar%20estes%20efeitos%20vasculares.%3Cbr%3E%20A%20tadalafila%20%26%23xE9%3B%20absorvida%20pelo%20organismo%20num%20tempo%20m%26%23xE9%3Bdio%20de%202%20horas%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral.%3Cbr%3E%20%3Cbr%3E%203.%20QUANDO%20N%26%23xC3%3BO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicado%20para%20homens%20que%20n%26%23xE3%3Bo%20apresentam%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%2Fou%20sinais%20e%20sintomas%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB).%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20deve%20ser%20usada%20por%20pacientes%20al%26%23xE9%3Brgicos%20%26%23xE0%3B%20tadalafila%20ou%20a%20qualquer%20um%20dos%20componentes%20do%20comprimido.%20A%20tadalafila%20n%26%23xE3%3Bo%20deve%20ser%20administrada%20a%20pacientes%20que%20estejam%20utilizando%20medicamentos%20contendo%20nitratos%2C%20tais%20como%3A%20propatilnitrato%20(Sustrate%26%23xAE%3B)%2C%20isossorbida%20(Monocordil%26%23xAE%3B%2C%20Cincordil%26%23xAE%3B%2C%20Isordil%26%23xAE%3B)%2C%20nitroglicerina%20(Nitradisc%26%23xAE%3B%2C%20Nitroderm%20TTS%26%23xAE%3B%2C%20Nitronal%26%23xAE%3B%2C%20Tridil%26%23xAE%3B)%20e%20dinitrato%20de%20isossorbitol%20(Isocord%26%23xAE%3B).%3Cbr%3E%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20recomenda%26%23xE7%3B%26%23xF5%3Bes%20e%20advert%26%23xEA%3Bncias%20especiais%20quanto%20ao%20uso%20de%20tadalafila%20por%20idosos.%3Cbr%3E%20%3Cbr%3E%204.%20O%20QUE%20DEVO%20SABER%20ANTES%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%20Advert%26%23xEA%3Bncias%20e%20Precau%26%23xE7%3B%26%23xF5%3Bes%3Cbr%3E%20Este%20medicamento%20deve%20ser%20administrado%20com%20cuidado%20%26%23xE0%3Bqueles%20pacientes%20que%20apresentem%20um%20dos%20seguintes%20problemas%20de%20sa%26%23xFA%3Bde%3A%20problemas%20do%20cora%26%23xE7%3B%26%23xE3%3Bo%2C%20tais%20como%20angina%20(dor%20no%20peito)%2C%20insufici%26%23xEA%3Bncia%20card%26%23xED%3Baca%2C%20batimentos%20card%26%23xED%3Bacos%20irregulares%20ou%20que%20tenham%20tido%20ataque%20card%26%23xED%3Baco%3B%20press%26%23xE3%3Bo%20baixa%20ou%20press%26%23xE3%3Bo%20alta%20n%26%23xE3%3Bo%20controlada%3B%20derrame%3B%20problemas%20de%20f%26%23xED%3Bgado%3B%20problemas%20com%20os%20rins%20ou%20que%20necessitem%20de%20di%26%23xE1%3Blise%3B%20%26%23xFA%3Blceras%20no%20est%26%23xF4%3Bmago%3B%20problemas%20de%20sangramento%3B%20deforma%26%23xE7%3B%26%23xE3%3Bo%20do%20p%26%23xEA%3Bnis%20ou%20doen%26%23xE7%3Ba%20de%20Peyronie%3B%20condi%26%23xE7%3B%26%23xF5%3Bes%20que%20predisp%26%23xF5%3Bem%20ao%20priapismo%20(ere%26%23xE7%3B%26%23xE3%3Bo%20com%20mais%20de%20quatro%20horas)%2C%20tais%20como%20anemia%20falciforme%2C%20mieloma%20m%26%23xFA%3Bltiplo%20ou%20leucemia.%20Lembrando%20tamb%26%23xE9%3Bm%20que%20a%20atividade%20sexual%20pode%20ser%20desaconselhada%20em%20pacientes%20com%20doen%26%23xE7%3Bas%20card%26%23xED%3Bacas%20graves%2C%20assim%20como%20os%20exerc%26%23xED%3Bcios%20f%26%23xED%3Bsicos%20em%20geral.%20O%20m%26%23xE9%3Bdico%20sempre%20dever%26%23xE1%3B%20ser%20informado%20sobre%20os%20problemas%20card%26%23xED%3Bacos%20do%20paciente%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(DE)%20e%2C%20ent%26%23xE3%3Bo%2C%20ele%20decidir%26%23xE1%3B%20qual%20%26%23xE9%3B%20o%20tratamento%20mais%20adequado%20para%20a%20DE.%3Cbr%3E%20Foram%20relatados%20raros%20casos%20de%20perda%20de%20vis%26%23xE3%3Bo%20em%20homens%20tomando%20medicamentos%20para%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20incluindo%20tadalafila.%20Este%20tipo%20de%20perda%20de%20vis%26%23xE3%3Bo%20%26%23xE9%3B%20chamado%20de%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(interrup%26%23xE7%3B%26%23xE3%3Bo%20do%20fluxo%20sangu%26%23xED%3Bneo%20para%20o%20nervo%20%26%23xF3%3Bptico).%20At%26%23xE9%3B%20o%20momento%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20esses%20medicamentos%20causam%20realmente%20este%20tipo%20de%20problema%2C%20pois%20ele%20tamb%26%23xE9%3Bm%20acontece%20em%20homens%20que%20n%26%23xE3%3Bo%20os%20tomam.%20Pessoas%20que%20t%26%23xEA%3Bm%20diabetes%2C%20press%26%23xE3%3Bo%20alta%2C%20aumento%20da%20taxa%20de%20colesterol%2C%20doen%26%23xE7%3Ba%20card%26%23xED%3Baca%20e%20fumantes%20t%26%23xEA%3Bm%20um%20risco%20mais%20alto%20de%20ter%20esta%20doen%26%23xE7%3Ba%20ocular.%20Caso%20voc%26%23xEA%3B%20tenha%20altera%26%23xE7%3B%26%23xE3%3Bo%20na%20vis%26%23xE3%3Bo%20durante%20o%20tratamento%20com%20tadalafila%2C%20pare%20de%20tomar%20o%20medicamento%20e%20procure%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20recomendar%20aos%20pacientes%20que%20interrompam%20o%20uso%20de%20inibidores%20de%20fosfodiesterase%205%20(PDE5)%2C%20incluindo%20tadalafila%2C%20bem%20como%20a%20procurarem%20uma%20orienta%26%23xE7%3B%26%23xE3%3Bo%20especializada%20em%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20Este%20eventos%2C%20que%20podem%20estar%20acompanhados%20de%20zumbido%20e%20vertigem%2C%20foram%20relatados%20na%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20%26%23xE0%3B%20introdu%26%23xE7%3B%26%23xE3%3Bo%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20de%20inibidores%20PDE5%20ou%20a%20outros%20fatores.%3Cbr%3E%20Pacientes%20com%20suspeita%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%20devem%20ser%20examinados%20para%20descartar%20a%20presen%26%23xE7%3Ba%20de%20carcinoma%20prost%26%23xE1%3Btico.%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20uso%20em%20mulheres.%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20estudos%20de%20tadalafila%20em%20mulheres%20gr%26%23xE1%3Bvidas.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%20Portanto%2C%20deve%20ser%20usado%20com%20cautela%20em%20pacientes%20que%20apresentam%20intoler%26%23xE2%3Bncia%20%26%23xE0%3B%20lactose.%3Cbr%3E%20A%20efic%26%23xE1%3Bcia%20deste%20medicamento%20depende%20da%20capacidade%20funcional%20do%20paciente.%20%3Cbr%3E%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%3Cbr%3E%20Voc%26%23xEA%3B%20deve%20falar%20para%20o%20m%26%23xE9%3Bdico%20todos%20os%20medicamentos%20que%20usa%2C%20sejam%20os%20receitados%20ou%20n%26%23xE3%3Bo%2C%20principalmente%20os%20rem%26%23xE9%3Bdios%20para%20problemas%20de%20cora%26%23xE7%3B%26%23xE3%3Bo%2C%20press%26%23xE3%3Bo%20alta%2C%20problemas%20da%20pr%26%23xF3%3Bstata%2C%20antibi%26%23xF3%3Bticos%2C%20medicamentos%20para%20o%20tratamento%20da%20AIDS%2C%20medicamentos%20para%20o%20tratamento%20de%20infec%26%23xE7%3B%26%23xF5%3Bes%20causadas%20por%20fungos%20e%20leveduras%3B%20e%20medicamentos%20indicados%20para%20o%20tratamento%20de%20doen%26%23xE7%3Bas%20que%20afetem%20o%20est%26%23xF4%3Bmago%2C%20como%2C%20por%20exemplo%2C%20gastrite%20e%20%26%23xFA%3Blcera.%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20alco%26%23xF3%3Blicas%20e%20o%20%26%23xE1%3Blcool%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%20Em%20altas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C7%20g%2FKg)%2C%20a%20adi%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20n%26%23xE3%3Bo%20induziu%20diminui%26%23xE7%3B%26%23xE3%3Bo%20estatisticamente%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20m%26%23xE9%3Bdia.%20Em%20alguns%20indiv%26%23xED%3Bduos%2C%20foram%20observadas%20tontura%20postural%20e%20hipotens%26%23xE3%3Bo%20ortost%26%23xE1%3Btica%20(queda%20da%20press%26%23xE3%3Bo%20arterial%20ao%20levantar-se).%20Quando%20a%20tadalafila%20foi%20administrada%20com%20baixas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C6%20g%2FKg)%2C%20hipotens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20observada%20e%20tonturas%20ocorreram%20com%20frequ%26%23xEA%3Bncia%20similar%20ao%20%26%23xE1%3Blcool%20administrado%20isoladamente.%3Cbr%3E%20A%20tadalafila%20pode%20ser%20tomada%20com%20ou%20sem%20alimento.%3Cbr%3E%20N%26%23xE3%3Bo%20foram%20conduzidos%20estudos%20cl%26%23xED%3Bnicos%20com%20o%20prop%26%23xF3%3Bsito%20de%20investigar%20poss%26%23xED%3Bveis%20intera%26%23xE7%3B%26%23xF5%3Bes%20entre%20tadalafila%20e%20plantas%20medicinais%2C%20nicotina%2C%20testes%20laboratoriais%20e%20n%26%23xE3%3Bo%20laboratoriais.%3Cbr%3E%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%20ou%20cirurgi%26%23xE3%3Bo-dentista%20se%20voc%26%23xEA%3B%20est%26%23xE1%3B%20fazendo%20uso%20de%20algum%20outro%20medicamento.%20N%26%23xE3%3Bo%20use%20medicamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%20Pode%20ser%20perigoso%20para%20a%20sua%20sa%26%23xFA%3Bde.%3Cbr%3E%20%3Cbr%3E%205.%20ONDE%2C%20COMO%20E%20POR%20QUANTO%20TEMPO%20POSSO%20GUARDAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Conservar%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC).%3Cbr%3E%20%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vide%20embalagem.%3Cbr%3E%20N%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido.%20Guarde-o%20em%20sua%20embalagem%20original.%3Cbr%3E%20%3Cbr%3E%20Aspecto%20f%26%23xED%3Bsico%3A%20tadalafila%20apresenta-se%20na%20forma%20de%20comprimido%20revestido%2C%20branco%20sem%20vinco.%3Cbr%3E%20%3Cbr%3E%20Antes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%20Caso%20ele%20esteja%20no%20prazo%20de%20validade%20e%20voc%26%23xEA%3B%20observe%20alguma%20mudan%26%23xE7%3Ba%20no%20aspecto%2C%20consulte%20o%20farmac%26%23xEA%3Butico%20para%20saber%20se%20poder%26%23xE1%3B%20utiliz%26%23xE1%3B-lo.%3Cbr%3E%20Todo%20medicamento%20deve%20ser%20mantido%20forma%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3Cbr%3E%20%3Cbr%3E%206.%20COMO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Este%20medicamento%20deve%20ser%20administrado%20somente%20por%20via%20oral%20e%20ingerido%20inteiro%2C%20podendo%20ser%20tomado%20independente%20das%20refei%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%20%3Cbr%3E%20Modo%20de%20uso%3Cbr%3E%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20a%20dose%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%205%20mg%2C%20administrada%20uma%20vez%20ao%20dia%2C%20aproximadamente%20no%20mesmo%20hor%26%23xE1%3Brio.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ocorrer%20a%20crit%26%23xE9%3Brio%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%3A%20a%20dose%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%205%20mg%2C%20administrada%20uma%20vez%20ao%20dia%2C%20aproximadamente%20no%20mesmo%20hor%26%23xE1%3Brio.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ocorrer%20a%20crit%26%23xE9%3Brio%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%20Homens%20com%20insufici%26%23xEA%3Bncia%20renal%3A%20n%26%23xE3%3Bo%20%26%23xE9%3B%20necess%26%23xE1%3Brio%20o%20ajuste%20de%20dose%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20leve%20ou%20moderada.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20uma%20vez%20ao%20dia%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendada%20para%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20grave.%3Cbr%3E%20Siga%20a%20orienta%26%23xE7%3B%26%23xE3%3Bo%20de%20seu%20m%26%23xE9%3Bdico%2C%20respeitando%20sempre%20os%20hor%26%23xE1%3Brios%2C%20as%20doses%20e%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento.%20N%26%23xE3%3Bo%20interrompa%20o%20tratamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20pode%20ser%20partido%2C%20aberto%20ou%20mastigado.%3Cbr%3E%20%3Cbr%3E%207.%20O%20QUE%20DEVO%20FAZER%20QUANDO%20EU%20ME%20ESQUECER%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20N%26%23xE3%3Bo%20administrar%20mais%20que%20a%20quantidade%20total%20de%20tadalafila%20recomendada%20pelo%20m%26%23xE9%3Bdico%20para%20per%26%23xED%3Bodos%20de%2024%20horas.%20Caso%20se%20esque%26%23xE7%3Ba%20de%20tomar%20uma%20dose%2C%20dever%26%23xE1%3B%20tom%26%23xE1%3B-la%20assim%20que%20lembrar.%3Cbr%3E%20Em%20caso%20de%20d%26%23xFA%3Bvidas%2C%20procure%20orienta%26%23xE7%3B%26%23xE3%3Bo%20do%20farmac%26%23xEA%3Butico%20ou%20de%20seu%20m%26%23xE9%3Bdico%2C%20ou%20cirurgi%26%23xE3%3Bo-dentista.%3Cbr%3E%20%3Cbr%3E%208.%20QUAIS%20OS%20MALES%20QUE%20ESTE%20MEDICAMENTO%20PODE%20ME%20CAUSAR%3F%3Cbr%3E%20Durante%20os%20estudos%20cl%26%23xED%3Bnicos%20para%20o%20tratamento%20de%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%20com%20o%20uso%20de%20tadalafila%205%20mg%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20comum%20(ocorre%20entre%201%25%20e%2010%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20lombalgia%20(dor%20nas%20costas)%2C%20dispepsia%20(indigest%26%23xE3%3Bo)%2C%20rubor%20facial%20(vermelhid%26%23xE3%3Bo%20no%20rosto)%2C%20mialgia%20(dor%20muscular)%20e%20congest%26%23xE3%3Bo%20nasal%20(nariz%20entupido).%20Rea%26%23xE7%3B%26%23xE3%3Bo%20incomum%20(ocorre%20entre%200%2C1%25%20e%201%25%20dos%20pacientes%20que%20utilizam%20esse%20medicamento)%3A%20dispneia%20(falta%20de%20ar).%3Cbr%3E%20%3Cbr%3E%20Durante%20os%20estudos%20cl%26%23xED%3Bnicos%20para%20o%20tratamento%20de%20Hiperplasia%20Prost%26%23xE1%3Btica%20Benigna%20(HPB)%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%20com%20o%20uso%20de%20tadalafila%205%20mg%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20comum%20(ocorre%20entre%201%25%20e%2010%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20cefaleia%20(dor%20de%20cabe%26%23xE7%3Ba)%2C%20dispepsia%20(indigest%26%23xE3%3Bo)%2C%20dor%20nas%20extremidades%2C%20mialgia%20(dor%20muscular)%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20No%20acompanhamento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20muito%20rara%20(ocorre%20em%20menos%20de%200%2C01%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%3Cbr%3E%20%3Cbr%3E%20Corpo%20como%20um%20todo%3A%20rea%26%23xE7%3B%26%23xF5%3Bes%20de%20hipersensibilidade%2C%20incluindo%20erup%26%23xE7%3B%26%23xE3%3Bo%20cut%26%23xE2%3Bnea%20(rea%26%23xE7%3B%26%23xE3%3Bo%20da%20pele%20caracterizada%20por%20vermelhid%26%23xE3%3Bo)%20e%20urtic%26%23xE1%3Bria%20(coceira)%2C%20incha%26%23xE7%3Bo%20facial%2C%20s%26%23xED%3Bndrome%20de%20Stevens-Johnson%20(doen%26%23xE7%3Ba%20com%20grave%20descama%26%23xE7%3B%26%23xE3%3Bo%20generalizada%20da%20pele)%20e%20dermatite%20esfoliativa%20(vermelhid%26%23xE3%3Bo%20inflamat%26%23xF3%3Bria%20da%20pele%20com%20descama%26%23xE7%3B%26%23xE3%3Bo%20generalizada).%3Cbr%3E%20%3Cbr%3E%20Cardiovascular%20e%20cerebrovascular%3A%20eventos%20cardiovasculares%20graves%2C%20incluindo%20infarto%20do%20mioc%26%23xE1%3Brdio%2C%20morte%20s%26%23xFA%3Bbita%20card%26%23xED%3Baca%2C%20acidente%20vascular%20cerebral%20(derrame%20cerebral)%2C%20dor%20no%20peito%2C%20palpita%26%23xE7%3B%26%23xF5%3Bes%20e%20taquicardia%20(aumento%20dos%20batimentos%20card%26%23xED%3Bacos)%20foram%20relatados%20na%20fase%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20tadalafila.%20A%20maioria%20dos%20pacientes%20que%20relatou%20esses%20eventos%20tinha%20fatores%20de%20risco%20cardiovascular%20pr%26%23xE9%3B-existentes.%20Entretanto%2C%20n%26%23xE3%3Bo%20se%20pode%20determinar%20definitivamente%20se%20esses%20eventos%20s%26%23xE3%3Bo%20relacionados%20diretamente%20a%20esses%20fatores%20de%20risco%2C%20%26%23xE0%3B%20tadalafila%2C%20%26%23xE0%3B%20atividade%20sexual%2C%20ou%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20e%20outros%20fatores.%3Cbr%3E%20Outros%20eventos%3A%20hipotens%26%23xE3%3Bo%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea)%20(mais%20comumente%20relatada%20quando%20tadalafila%20%26%23xE9%3B%20usada%20por%20pacientes%20que%20j%26%23xE1%3B%20est%26%23xE3%3Bo%20tomando%20agentes%20anti-hipertensivos)%2C%20hipertens%26%23xE3%3Bo%20(aumento%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea)%20e%20s%26%23xED%3Bncope%20(desmaio).%3Cbr%3E%20%3Cbr%3E%20Gastrointestinal%3A%20dor%20abdominal%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20Pele%20e%20tecidos%20subcut%26%23xE2%3Bneos%3A%20hiperidrose%20(suor%20em%20excesso).%3Cbr%3E%20%3Cbr%3E%20Sentidos%20especiais%3A%20vis%26%23xE3%3Bo%20borrada%2C%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(interrup%26%23xE7%3B%26%23xE3%3Bo%20do%20fluxo%20sangu%26%23xED%3Bneo%20para%20o%20nervo%20%26%23xF3%3Bptico)%20podendo%20resultar%20na%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20vis%26%23xE3%3Bo%2C%20oclus%26%23xE3%3Bo%20(obstru%26%23xE7%3B%26%23xE3%3Bo)%20da%20veia%20retiniana%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20(altera%26%23xE7%3B%26%23xE3%3Bo)%20do%20campo%20visual.%3Cbr%3E%20%3Cbr%3E%20Urogenital%3A%20priapismo%20(ere%26%23xE7%3B%26%23xE3%3Bo%20persistente%20do%20p%26%23xEA%3Bnis%20acompanhado%20de%20dor)%20e%20ere%26%23xE7%3B%26%23xE3%3Bo%20prolongada.%3Cbr%3E%20%3Cbr%3E%20Sistema%20Nervoso%3A%20enxaqueca%20(dor%20de%20cabe%26%23xE7%3Ba).%3Cbr%3E%20%3Cbr%3E%20Sistema%20Respirat%26%23xF3%3Brio%3A%20epistaxe%20(sangramento%20pelo%20nariz).%3Cbr%3E%20%3Cbr%3E%20Audi%26%23xE7%3B%26%23xE3%3Bo%3A%20na%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20foram%20relatados%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20da%20audi%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20Em%20alguns%20casos%2C%20foram%20relatadas%20condi%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdicas%20e%20outros%20fatores%20que%20podem%20igualmente%20ter%20causado%20eventos%20adversos%20auditivos.%20Em%20muitos%20casos%2C%20a%20informa%26%23xE7%3B%26%23xE3%3Bo%20no%20acompanhamento%20m%26%23xE9%3Bdico%20foi%20limitada.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20relacionados%20diretamente%20ao%20uso%20de%20tadalafila%2C%20a%20fatores%20de%20risco%20subjacentes%20do%20paciente%20para%20a%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%2C%20uma%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20fatores%20ou%20a%20outros%20fatores.%3Cbr%3E%20Aten%26%23xE7%3B%26%23xE3%3Bo%3A%20este%20produto%20%26%23xE9%3B%20um%20medicamento%20que%20possui%20nova%20concentra%26%23xE7%3B%26%23xE3%3Bo%20e%20nova%20indica%26%23xE7%3B%26%23xE3%3Bo%20terap%26%23xEA%3Butica%20no%20pa%26%23xED%3Bs%20e%2C%20embora%20as%20pesquisas%20tenham%20indicado%20efic%26%23xE1%3Bcia%20e%20seguran%26%23xE7%3Ba%20aceit%26%23xE1%3Bveis%2C%20mesmo%20que%20indicado%20e%20utilizado%20corretamente%2C%20podem%20ocorrer%20eventos%20adversos%20imprevis%26%23xED%3Bveis%20ou%20desconhecidos.%20Nesse%20caso%2C%20informe%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20%3Cbr%3E%209.%20O%20QUE%20FAZER%20SE%20ALGU%26%23xC9%3BM%20USAR%20UMA%20QUANTIDADE%20MAIOR%20DO%20QUE%20A%20INDICADA%20DESTE%20MEDICAMENTO%3F%3Cbr%3E%20Doses%20%26%23xFA%3Bnicas%20de%20at%26%23xE9%3B%20500%20mg%20de%20tadalafila%20foram%20administradas%20a%20indiv%26%23xED%3Bduos%20sadios%20e%2C%20doses%20m%26%23xFA%3Bltiplas%20di%26%23xE1%3Brias%20de%20at%26%23xE9%3B%20100%20mg%20de%20tadalafila%2C%20a%20pacientes.%20Os%20eventos%20adversos%20foram%20similares%20%26%23xE0%3Bqueles%20observados%20com%20doses%20menores.%20Em%20casos%20de%20superdose%2C%20medidas%20de%20suporte%20padr%26%23xE3%3Bo%20devem%20ser%20adotadas%20conforme%20necess%26%23xE1%3Brio.%20Hemodi%26%23xE1%3Blise%20contribui%20de%20modo%20desprez%26%23xED%3Bvel%20para%20a%20elimina%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila.%3Cbr%3E%20Em%20caso%20de%20uso%20de%20grande%20quantidade%20deste%20medicamento%2C%20procure%20rapidamente%20socorro%20m%26%23xE9%3Bdico%20e%20leve%20a%20embalagem%20ou%20bula%20do%20medicamento%2C%20se%20poss%26%23xED%3Bvel.%20Ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%20%3Cbr%3E%20Venda%20sob%20prescri%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica.%3Cbr%3E%20M.S.%3A%201.0043.1103%3Cbr%3E%20Farm.%20Resp.%3A%20Dra.%20S%26%23xF4%3Bnia%20Albano%20Badar%26%23xF3%3B%20%26%23x96%3B%20CRF-SP%2019.258%3Cbr%3E%20%3Cbr%3E%20Fabricado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Rod.%20Pres.%20Castelo%20Branco%2C%20km%2035%2C6%20%26%23x2013%3B%20Itapevi%20%26%23x96%3B%20SP%3Cbr%3E%20%3Cbr%3E%20Registrado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Av.%20Vereador%20Jos%26%23xE9%3B%20Diniz%2C%203.465%20%26%23x2013%3B%20S%26%23xE3%3Bo%20Paulo%20%26%23x2013%3B%20SP%3Cbr%3E%20CNPJ%3A%2061.190.096%2F0001-92%3Cbr%3E%20Ind%26%23xFA%3Bstria%20Brasileira%3Cbr%3E%20_____________________________________________________________________%3Cbr%3E%20%3Cbr%3E%20Comprimido%20revestido%3Cbr%3E%2020%20mg%3Cbr%3E%20%3Cbr%3E%20FORMA%20FARMAC%26%23xCA%3BUTICA%20E%20APRESENTA%26%23xC7%3B%26%23xC3%3BO%20%20%3Cbr%3E%20Embalagem%20com%202%20comprimidos%20contendo%2020%20mg%20de%20tadalafila.%20%20%3Cbr%3E%20%3Cbr%3E%20EXCLUSIVAMENTE%20PARA%20ADMINISTRA%26%23xC7%3B%26%23xC3%3BO%20ORAL%20%20%3Cbr%3E%20USO%20ADULTO%20ACIMA%20DE%2018%20ANOS%20%20%3Cbr%3E%20%3Cbr%3E%20COMPOSI%26%23xC7%3B%26%23xC3%3BO%20%20%3Cbr%3E%20Cada%20comprimido%20cont%26%23xE9%3Bm%3A%20%20%3Cbr%3E%20tadalafila%20%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B20%20mg%3Cbr%3E%20excipientes%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B.1%20comprimido%3Cbr%3E%20Excipientes%3A%20lactose%2C%20lactose%20monoidratada%2C%20hiprolose%2C%20laurilsulfato%20de%20s%26%23xF3%3Bdio%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20celulose%20microcristalina%2C%20di%26%23xF3%3Bxido%20de%20sil%26%23xED%3Bcio%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20hipromelose%2C%20triacetina%20e%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio.%3Cbr%3E%20%3Cbr%3E%201.%20PARA%20QUE%20ESTE%20MEDICAMENTO%20%26%23xC9%3B%20INDICADO%3F%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20indicado%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20%3Cbr%3E%202.%20COMO%20ESTE%20MEDICAMENTO%20FUNCIONA%3F%3Cbr%3E%20Defini%26%23xE7%3B%26%23xE3%3Bo%20de%20Disfun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%3A%20quando%20existe%20um%20est%26%23xED%3Bmulo%20sexual%2C%20o%20p%26%23xEA%3Bnis%20se%20enche%20de%20sangue%20e%20o%20homem%20tem%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20Se%20o%20homem%20tiver%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(DE)%2C%20o%20p%26%23xEA%3Bnis%20n%26%23xE3%3Bo%20se%20enche%20de%20sangue%20de%20forma%20adequada%20e%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20%26%23xE9%3B%20suficiente%20para%20ocorrer%20uma%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20A%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20tamb%26%23xE9%3Bm%20chamada%20de%20impot%26%23xEA%3Bncia%20sexual%2C%20pode%20ter%20diversas%20causas.%20%26%23xC9%3B%20importante%20consultar%20um%20m%26%23xE9%3Bdico%20para%20descobrir%20a%20natureza%20desse%20problema.%20A%20tadalafila%20pode%20ajudar%20o%20homem%20com%20DE%20a%20obter%20e%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20quando%20estiver%20sexualmente%20excitado.%3Cbr%3E%20%3Cbr%3E%20A%26%23xE7%3B%26%23xE3%3Bo%20do%20medicamento%3A%20tadalafila%20%26%23xE9%3B%20um%20medicamento%20para%20o%20tratamento%20da%20dificuldade%20de%20obten%26%23xE7%3B%26%23xE3%3Bo%20e%2Fou%20manuten%26%23xE7%3B%26%23xE3%3Bo%20da%20ere%26%23xE7%3B%26%23xE3%3Bo%20do%20p%26%23xEA%3Bnis%20(disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil).%20Quando%20um%20homem%20%26%23xE9%3B%20sexualmente%20estimulado%2C%20a%20resposta%20f%26%23xED%3Bsica%20normal%20do%20seu%20corpo%20%26%23xE9%3B%20o%20aumento%20do%20fluxo%20sangu%26%23xED%3Bneo%20no%20p%26%23xEA%3Bnis.%20Isso%20resulta%20em%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo.%20A%20tadalafila%20ajuda%20a%20aumentar%20o%20fluxo%20de%20sangue%20no%20p%26%23xEA%3Bnis%20e%20pode%20auxiliar%20homens%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20a%20obterem%20e%20manterem%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20satisfat%26%23xF3%3Bria%20para%20a%20atividade%20sexual.%20Uma%20vez%20completa%20a%20atividade%20sexual%2C%20o%20fluxo%20sangu%26%23xED%3Bneo%20do%20p%26%23xEA%3Bnis%20diminui%20e%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20termina.%20Para%20tadalafila%20funcionar%2C%20%26%23xE9%3B%20necess%26%23xE1%3Bria%20uma%20excita%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20O%20homem%20n%26%23xE3%3Bo%20ter%26%23xE1%3B%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20apenas%20por%20tomar%20um%20comprimido%20de%20tadalafila%2C%20sem%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20A%20tadalafila%20age%2C%20em%20m%26%23xE9%3Bdia%2C%20a%20partir%20de%2030%20minutos%2C%20podendo%20ter%20a%26%23xE7%3B%26%23xE3%3Bo%20por%20at%26%23xE9%3B%2036%20horas.%3Cbr%3E%20%3Cbr%3E%203.%20QUANDO%20N%26%23xC3%3BO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicado%20para%20homens%20que%20n%26%23xE3%3Bo%20apresentam%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20usado%20por%20pacientes%20al%26%23xE9%3Brgicos%20%26%23xE0%3B%20tadalafila%20ou%20a%20qualquer%20um%20dos%20componentes%20do%20comprimido.%20A%20tadalafila%20n%26%23xE3%3Bo%20deve%20ser%20administrada%20a%20pacientes%20que%20estejam%20utilizando%20medicamentos%20contendo%20nitratos%2C%20tais%20como%3A%20propatilnitrato%20(Sustrate%26%23xAE%3B)%2C%20isossorbida%20(Monocordil%26%23xAE%3B%2C%20Cincordil%26%23xAE%3B%2C%20Isordil%26%23xAE%3B)%2C%20nitroglicerina%20(Nitradisc%26%23xAE%3B%2C%20Nitroderm%20TTS%26%23xAE%3B%2C%20Nitronal%26%23xAE%3B%2C%20Tridil%26%23xAE%3B)%20e%20dinitrato%20de%20isossorbitol%20(Isocord%26%23xAE%3B).%3Cbr%3E%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20recomenda%26%23xE7%3B%26%23xF5%3Bes%20e%20advert%26%23xEA%3Bncias%20especiais%20quanto%20ao%20uso%20de%20tadalafila%20por%20idosos.%3Cbr%3E%20%3Cbr%3E%204.%20O%20QUE%20DEVO%20SABER%20ANTES%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%20Advert%26%23xEA%3Bncias%20e%20Precau%26%23xE7%3B%26%23xF5%3Bes%3Cbr%3E%20A%20tadalafila%20deve%20ser%20administrada%20com%20cuidado%20%26%23xE0%3Bqueles%20pacientes%20que%20apresentem%20um%20dos%20seguintes%20problemas%20de%20sa%26%23xFA%3Bde%3A%20problemas%20card%26%23xED%3Bacos%2C%20tais%20como%20angina%20(dor%20no%20peito)%2C%20insufici%26%23xEA%3Bncia%20card%26%23xED%3Baca%2C%20batimentos%20card%26%23xED%3Bacos%20irregulares%20ou%20que%20tenham%20tido%20ataque%20card%26%23xED%3Baco%3B%20press%26%23xE3%3Bo%20baixa%20ou%20press%26%23xE3%3Bo%20alta%20n%26%23xE3%3Bo%20controlada%3B%20derrame%3B%20problemas%20de%20f%26%23xED%3Bgado%3B%20problemas%20com%20os%20rins%20ou%20que%20necessitem%20de%20di%26%23xE1%3Blise%3B%20%26%23xFA%3Blceras%20no%20est%26%23xF4%3Bmago%3B%20problemas%20de%20sangramento%3B%20deforma%26%23xE7%3B%26%23xE3%3Bo%20do%20p%26%23xEA%3Bnis%20ou%20doen%26%23xE7%3Ba%20de%20Peyronie%3B%20condi%26%23xE7%3B%26%23xF5%3Bes%20que%20predisp%26%23xF5%3Bem%20ao%20priapismo%20(ere%26%23xE7%3B%26%23xE3%3Bo%20com%20mais%20de%20quatro%20horas)%2C%20tais%20como%20anemia%20falciforme%2C%20mieloma%20m%26%23xFA%3Bltiplo%20ou%20leucemia.%20Lembrando%20tamb%26%23xE9%3Bm%20que%20a%20atividade%20sexual%20pode%20ser%20desaconselhada%20em%20pacientes%20com%20doen%26%23xE7%3Bas%20card%26%23xED%3Bacas%20graves%2C%20assim%20como%20os%20exerc%26%23xED%3Bcios%20f%26%23xED%3Bsicos%20em%20geral.%20O%20m%26%23xE9%3Bdico%20sempre%20dever%26%23xE1%3B%20ser%20informado%20sobre%20os%20problemas%20card%26%23xED%3Bacos%20do%20paciente%20com%20DE%20e%2C%20ent%26%23xE3%3Bo%2C%20ele%20decidir%26%23xE1%3B%20qual%20%26%23xE9%3B%20o%20tratamento%20mais%20adequado%20para%20a%20DE.%3Cbr%3E%20Foram%20relatados%20raros%20casos%20de%20perda%20de%20vis%26%23xE3%3Bo%20em%20homens%20tomando%20medicamentos%20para%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20incluindo%20tadalafila.%20Este%20tipo%20de%20perda%20de%20vis%26%23xE3%3Bo%20%26%23xE9%3B%20chamado%20de%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(interrup%26%23xE7%3B%26%23xE3%3Bo%20do%20fluxo%20sangu%26%23xED%3Bneo%20para%20o%20nervo%20%26%23xF3%3Bptico).%20At%26%23xE9%3B%20o%20momento%2C%20n%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20esses%20medicamentos%20causam%20realmente%20este%20tipo%20de%20problema%2C%20pois%20ele%20tamb%26%23xE9%3Bm%20acontece%20em%20homens%20que%20n%26%23xE3%3Bo%20os%20tomam.%20Pessoas%20que%20t%26%23xEA%3Bm%20diabetes%2C%20press%26%23xE3%3Bo%20alta%2C%20aumento%20da%20taxa%20de%20colesterol%2C%20doen%26%23xE7%3Ba%20card%26%23xED%3Baca%20e%20fumantes%20t%26%23xEA%3Bm%20um%20risco%20mais%20alto%20de%20ter%20esta%20doen%26%23xE7%3Ba%20ocular.%20Caso%20voc%26%23xEA%3B%20tenha%20altera%26%23xE7%3B%26%23xE3%3Bo%20na%20vis%26%23xE3%3Bo%20durante%20o%20tratamento%20com%20tadalafila%2C%20pare%20de%20tomar%20o%20medicamento%20e%20procure%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20Os%20m%26%23xE9%3Bdicos%20devem%20recomendar%20aos%20pacientes%20que%20interrompam%20o%20uso%20de%20inibidores%20de%20fosfodiesterase%205%20(PDE5)%2C%20incluindo%20tadalafila%2C%20bem%20como%20a%20procurarem%20uma%20orienta%26%23xE7%3B%26%23xE3%3Bo%20especializada%20em%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20Este%20eventos%2C%20que%20podem%20estar%20acompanhados%20de%20zumbido%20e%20vertigem%2C%20foram%20relatados%20na%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20%26%23xE0%3B%20introdu%26%23xE7%3B%26%23xE3%3Bo%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20diretamente%20relacionados%20ao%20uso%20de%20inibidores%20PDE5%20ou%20a%20outros%20fatores.%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicada%20para%20uso%20em%20mulheres.%20N%26%23xE3%3Bo%20h%26%23xE1%3B%20estudos%20de%20tadalafila%20em%20mulheres%20gr%26%23xE1%3Bvidas.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%20Portanto%2C%20deve%20ser%20usado%20com%20cautela%20em%20pacientes%20que%20apresentam%20intoler%26%23xE2%3Bncia%20%26%23xE0%3B%20lactose.%3Cbr%3E%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%3Cbr%3E%20Voc%26%23xEA%3B%20deve%20falar%20para%20o%20m%26%23xE9%3Bdico%20todos%20os%20medicamentos%20que%20usa%2C%20sejam%20os%20receitados%20ou%20n%26%23xE3%3Bo%2C%20principalmente%20os%20rem%26%23xE9%3Bdios%20para%20problemas%20de%20cora%26%23xE7%3B%26%23xE3%3Bo%2C%20press%26%23xE3%3Bo%20alta%2C%20problemas%20da%20pr%26%23xF3%3Bstata%2C%20antibi%26%23xF3%3Bticos%2C%20medicamentos%20para%20o%20tratamento%20da%20AIDS%2C%20medicamentos%20para%20o%20tratamento%20de%20infec%26%23xE7%3B%26%23xF5%3Bes%20causadas%20por%20fungos%20e%20leveduras%3B%20e%20medicamentos%20indicados%20para%20o%20tratamento%20de%20doen%26%23xE7%3Bas%20que%20afetem%20o%20est%26%23xF4%3Bmago%2C%20como%2C%20por%20exemplo%2C%20gastrite%20e%20%26%23xFA%3Blcera.%3Cbr%3E%20A%20tadalafila%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20alco%26%23xF3%3Blicas%20e%20o%20%26%23xE1%3Blcool%20n%26%23xE3%3Bo%20afetou%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20tadalafila.%20Em%20altas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C7%20g%2FKg)%2C%20a%20adi%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%20n%26%23xE3%3Bo%20induziu%20diminui%26%23xE7%3B%26%23xE3%3Bo%20estatisticamente%20significativa%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20m%26%23xE9%3Bdia.%20Em%20alguns%20indiv%26%23xED%3Bduos%2C%20foram%20observadas%20tontura%20postural%20e%20hipotens%26%23xE3%3Bo%20ortost%26%23xE1%3Btica%20(queda%20da%20press%26%23xE3%3Bo%20arterial%20ao%20levantar-se).%20Quando%20a%20tadalafila%20foi%20administrada%20com%20baixas%20doses%20de%20%26%23xE1%3Blcool%20(0%2C6%20g%2FKg)%2C%20hipotens%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20observada%20e%20tonturas%20ocorreram%20com%20frequ%26%23xEA%3Bncia%20similar%20ao%20%26%23xE1%3Blcool%20administrado%20isoladamente.%3Cbr%3E%20A%20tadalafila%20pode%20ser%20tomada%20com%20ou%20sem%20alimento.%3Cbr%3E%20N%26%23xE3%3Bo%20foram%20conduzidos%20estudos%20cl%26%23xED%3Bnicos%20com%20o%20prop%26%23xF3%3Bsito%20de%20investigar%20poss%26%23xED%3Bveis%20intera%26%23xE7%3B%26%23xF5%3Bes%20entre%20tadalafila%20e%20plantas%20medicinais%2C%20nicotina%2C%20testes%20laboratoriais%20e%20n%26%23xE3%3Bo%20laboratoriais.%3Cbr%3E%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%20ou%20cirurgi%26%23xE3%3Bo-dentista%20se%20voc%26%23xEA%3B%20est%26%23xE1%3B%20fazendo%20uso%20de%20algum%20outro%20medicamento.%20N%26%23xE3%3Bo%20use%20medicamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%20Pode%20ser%20perigoso%20para%20a%20sua%20sa%26%23xFA%3Bde.%3Cbr%3E%20%3Cbr%3E%205.%20ONDE%2C%20COMO%20E%20POR%20QUANTO%20TEMPO%20POSSO%20GUARDAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Conservar%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC).%3Cbr%3E%20%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vide%20embalagem.%3Cbr%3E%20N%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido.%20Guarde-o%20em%20sua%20embalagem%20original.%3Cbr%3E%20%3Cbr%3E%20Aspecto%20f%26%23xED%3Bsico%3A%20tadalafila%20apresenta-se%20na%20forma%20de%20comprimido%20revestido%2C%20branco%20sem%20vinco.%3Cbr%3E%20%3Cbr%3E%20Antes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%20Caso%20ele%20esteja%20no%20prazo%20de%20validade%20e%20voc%26%23xEA%3B%20observe%20alguma%20mudan%26%23xE7%3Ba%20no%20aspecto%2C%20consulte%20o%20farmac%26%23xEA%3Butico%20para%20saber%20se%20poder%26%23xE1%3B%20utiliz%26%23xE1%3B-lo.%3Cbr%3E%20Todo%20medicamento%20deve%20ser%20mantido%20fora%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3Cbr%3E%20%3Cbr%3E%206.%20COMO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Este%20medicamento%20deve%20ser%20administrado%20somente%20por%20via%20oral%20e%20ingerido%20inteiro%2C%20podendo%20ser%20tomado%20independente%20das%20refei%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%20%3Cbr%3E%20Modo%20de%20uso%3Cbr%3E%20Dosagem%3A%20a%20dose%20m%26%23xE1%3Bxima%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%2020%20mg%2C%20tomada%20antes%20da%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20A%20frequ%26%23xEA%3Bncia%20m%26%23xE1%3Bxima%20de%20dose%20recomendada%20%26%23xE9%3B%20uma%20vez%20ao%20dia.%3Cbr%3E%20A%20tadalafila%20provou%20ser%20eficaz%20a%20partir%20de%2030%20minutos%20ap%26%23xF3%3Bs%20sua%20administra%26%23xE7%3B%26%23xE3%3Bo%2C%20por%20at%26%23xE9%3B%2036%20horas.%3Cbr%3E%20Pacientes%20podem%20iniciar%20a%20atividade%20sexual%20em%20tempos%20vari%26%23xE1%3Bveis%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20administra%26%23xE7%3B%26%23xE3%3Bo%2C%20de%20maneira%20a%20determinar%20seu%20pr%26%23xF3%3Bprio%20intervalo%20%26%23xF3%3Btimo%20de%20resposta.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ocorrer%20a%20crit%26%23xE9%3Brio%20m%26%23xE9%3Bdico.%3Cbr%3E%20Siga%20a%20orienta%26%23xE7%3B%26%23xE3%3Bo%20de%20seu%20m%26%23xE9%3Bdico%2C%20respeitando%20sempre%20os%20hor%26%23xE1%3Brios%2C%20as%20doses%20e%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento.%20N%26%23xE3%3Bo%20interrompa%20o%20tratamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20partido%2C%20aberto%20ou%20mastigado.%3Cbr%3E%20A%20efic%26%23xE1%3Bcia%20deste%20medicamento%20depende%20da%20capacidade%20funcional%20do%20paciente.%3Cbr%3E%20%3Cbr%3E%207.%20O%20QUE%20DEVO%20FAZER%20QUANDO%20EU%20ME%20ESQUECER%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20A%20dose%20m%26%23xE1%3Bxima%20di%26%23xE1%3Bria%20recomendada%20de%20tadalafila%20%26%23xE9%3B%20de%2020%20mg%2C%20tomada%20antes%20da%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20e%20independente%20das%20refei%26%23xE7%3B%26%23xF5%3Bes.%20Portanto%2C%20seu%20uso%20%26%23xE9%3B%20sob%20demanda.%3Cbr%3E%20Em%20caso%20de%20d%26%23xFA%3Bvidas%2C%20procure%20orienta%26%23xE7%3B%26%23xE3%3Bo%20do%20farmac%26%23xEA%3Butico%20ou%20de%20seu%20m%26%23xE9%3Bdico%2C%20ou%20cirurgi%26%23xE3%3Bo-dentista.%3Cbr%3E%20%3Cbr%3E%208.%20QUAIS%20OS%20MALES%20QUE%20ESTE%20MEDICAMENTO%20PODE%20ME%20CAUSAR%3F%3Cbr%3E%20Nos%20estudos%20cl%26%23xED%3Bnicos%2C%20foram%20relatadas%20as%20seguintes%20rea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20com%20o%20uso%20de%20tadalafila%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Muito%20Comum%20(ocorre%20em%2010%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20cefaleia%20(dor%20de%20cabe%26%23xE7%3Ba).%3Cbr%3E%20%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Comum%20(ocorre%20entre%201%25%20e%2010%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20dor%20nas%20costas%2C%20tontura%2C%20dispepsia%20(indisposi%26%23xE7%3B%26%23xE3%3Bo%20g%26%23xE1%3Bstrica)%2C%20rubor%20facial%20(vermelhid%26%23xE3%3Bo%20no%20rosto)%2C%20mialgia%20(dor%20muscular)%20e%20congest%26%23xE3%3Bo%20nasal%20(nariz%20entupido).%3Cbr%3E%20%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Incomum%20(ocorre%20entre%200%2C1%25%20e%201%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20hiperemia%20conjuntival%20(vermelhid%26%23xE3%3Bo%20nos%20olhos)%2C%20sensa%26%23xE7%3B%26%23xF5%3Bes%20descritas%20como%20dor%20nos%20olhos%2C%20incha%26%23xE7%3Bo%20das%20p%26%23xE1%3Blpebras%20e%20dispneia%20(falta%20de%20ar).%3Cbr%3E%20%3Cbr%3E%20No%20acompanhamento%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20de%20tadalafila%2C%20os%20seguintes%20eventos%20adversos%20foram%20relatados%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20Muito%20Rara%20(ocorre%20em%20menos%20de%200%2C01%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%3Cbr%3E%20Corpo%20como%20um%20todo%3A%20rea%26%23xE7%3B%26%23xF5%3Bes%20de%20hipersensibilidade%2C%20incluindo%20erup%26%23xE7%3B%26%23xE3%3Bo%20cut%26%23xE2%3Bnea%2C%20urtic%26%23xE1%3Bria%20(erup%26%23xE7%3B%26%23xE3%3Bo%20da%20pele%20com%20coceira)%2C%20incha%26%23xE7%3Bo%20facial%2C%20s%26%23xED%3Bndrome%20de%20Stevens-Johnson%20(vermelhid%26%23xE3%3Bo%20inflamat%26%23xF3%3Bria%20grave%20da%20pele%20de%20formato%20bolhoso)%20e%20dermatite%20esfoliativa%20(vermelhid%26%23xE3%3Bo%20inflamat%26%23xF3%3Bria%20da%20pele%20com%20descama%26%23xE7%3B%26%23xE3%3Bo%20generalizada).%3Cbr%3E%20%3Cbr%3E%20Cardiovascular%20e%20cerebrovascular%3A%20eventos%20cardiovasculares%20graves%2C%20incluindo%20infarto%20do%20mioc%26%23xE1%3Brdio%2C%20morte%20s%26%23xFA%3Bbita%20card%26%23xED%3Baca%2C%20acidente%20vascular%20cerebral%20(derrame%20cerebral)%2C%20dor%20no%20peito%2C%20palpita%26%23xE7%3B%26%23xF5%3Bes%20e%20taquicardia%20(batimento%20card%26%23xED%3Baco%20acelerado)%20foram%20relatados%20na%20fase%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20e%20foi%20poss%26%23xED%3Bvel%20estabelecer%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20tadalafila.%20A%20maioria%20dos%20pacientes%20que%20relatou%20esses%20eventos%20tinham%20fatores%20de%20risco%20cardiovascular%20pr%26%23xE9%3B-existentes.%20Entretanto%2C%20n%26%23xE3%3Bo%20se%20pode%20determinar%20definitivamente%20se%20esses%20eventos%20s%26%23xE3%3Bo%20relacionados%20diretamente%20a%20esses%20fatores%20de%20risco%2C%20%26%23xE0%3B%20tadalafila%2C%20%26%23xE0%3B%20atividade%20sexual%2C%20ou%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20e%20outros%20fatores.%3Cbr%3E%20%3Cbr%3E%20Outros%20eventos%3A%20hipotens%26%23xE3%3Bo%20(diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea)%20(mais%20comumente%20relatada%20quando%20a%20tadalafila%20%26%23xE9%3B%20utilizada%20por%20pacientes%20que%20j%26%23xE1%3B%20est%26%23xE3%3Bo%20tomando%20agentes%20anti-hipertensivos)%2C%20hipertens%26%23xE3%3Bo%20(aumento%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea)%20e%20s%26%23xED%3Bncope%20(desmaio).%3Cbr%3E%20%3Cbr%3E%20Gastrointestinal%3A%20dor%20abdominal%20e%20refluxo%20gastroesof%26%23xE1%3Bgico.%3Cbr%3E%20%3Cbr%3E%20Pele%20e%20tecidos%20subcut%26%23xE2%3Bneos%3A%20hiperidrose%20(suor%20abundante).%3Cbr%3E%20%3Cbr%3E%20Sentidos%20especiais%3A%20vis%26%23xE3%3Bo%20borrada%2C%20neuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(interrup%26%23xE7%3B%26%23xE3%3Bo%20do%20fluxo%20sangu%26%23xED%3Bneo%20para%20o%20nervo%20%26%23xF3%3Bptico)%20podendo%20resultar%20na%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20vis%26%23xE3%3Bo%2C%20oclus%26%23xE3%3Bo%20(obstru%26%23xE7%3B%26%23xE3%3Bo)%20da%20veia%20retiniana%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20(altera%26%23xE7%3B%26%23xE3%3Bo)%20do%20campo%20visual.%3Cbr%3E%20%3Cbr%3E%20Urogenital%3A%20priapismo%20(ere%26%23xE7%3B%26%23xE3%3Bo%20dolorosa%20com%20mais%20de%204%20horas%20de%20dura%26%23xE7%3B%26%23xE3%3Bo)%20e%20ere%26%23xE7%3B%26%23xE3%3Bo%20prolongada.%3Cbr%3E%20%3Cbr%3E%20Sistema%20Nervoso%3A%20enxaqueca%20(dor%20de%20cabe%26%23xE7%3Ba)%3Cbr%3E%20%3Cbr%3E%20Sistema%20Respirat%26%23xF3%3Brio%3A%20epistaxe%20(sangramento%20pelo%20nariz).%3Cbr%3E%20%3Cbr%3E%20Audi%26%23xE7%3B%26%23xE3%3Bo%3A%20na%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20foram%20relatados%20casos%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20repentina%20da%20audi%26%23xE7%3B%26%23xE3%3Bo%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20de%20inibidores%20PDE5%2C%20incluindo%20tadalafila.%20Em%20alguns%20casos%2C%20foram%20relatadas%20condi%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdicas%20e%20outros%20fatores%20que%20podem%20igualmente%20ter%20causado%20eventos%20adversos%20auditivos.%20Em%20muitos%20casos%2C%20a%20informa%26%23xE7%3B%26%23xE3%3Bo%20no%20acompanhamento%20m%26%23xE9%3Bdico%20foi%20limitada.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20estes%20eventos%20est%26%23xE3%3Bo%20relacionados%20diretamente%20ao%20uso%20de%20tadalafila%2C%20a%20fatores%20de%20risco%20subjacentes%20do%20paciente%20para%20a%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%2C%20uma%20combina%26%23xE7%3B%26%23xE3%3Bo%20destes%20fatores%20ou%20a%20outros%20fatores.%3Cbr%3E%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%2C%20cirurgi%26%23xE3%3Bo-dentista%20ou%20farmac%26%23xEA%3Butico%20o%20aparecimento%20de%20rea%26%23xE7%3B%26%23xF5%3Bes%20indesej%26%23xE1%3Bveis%20pelo%20uso%20do%20medicamento.%20Informe%20tamb%26%23xE9%3Bm%20%26%23xE0%3B%20empresa%20atrav%26%23xE9%3Bs%20do%20seu%20servi%26%23xE7%3Bo%20de%20atendimento.%3Cbr%3E%20%3Cbr%3E%209.%20O%20QUE%20FAZER%20SE%20ALGU%26%23xC9%3BM%20USAR%20UMA%20QUANTIDADE%20MAIOR%20DO%20QUE%20A%20INDICADA%20DESTE%20MEDICAMENTO%3F%3Cbr%3E%20Doses%20%26%23xFA%3Bnicas%20de%20at%26%23xE9%3B%20500%20mg%20de%20tadalafila%20foram%20administradas%20a%20indiv%26%23xED%3Bduos%20sadios%20e%2C%20doses%20m%26%23xFA%3Bltiplas%20di%26%23xE1%3Brias%20de%20at%26%23xE9%3B%20100%20mg%20de%20tadalafila%2C%20a%20pacientes.%20Os%20eventos%20adversos%20foram%20similares%20%26%23xE0%3Bqueles%20observados%20com%20doses%20menores.%20Em%20casos%20de%20superdose%2C%20medidas%20de%20suporte%20padr%26%23xE3%3Bo%20devem%20ser%20adotadas%20conforme%20necess%26%23xE1%3Brio.%20Hemodi%26%23xE1%3Blise%20contribui%20de%20modo%20n%26%23xE3%3Bo%20significativo%20para%20a%20elimina%26%23xE7%3B%26%23xE3%3Bo%20da%20tadalafila.%3Cbr%3E%20Em%20caso%20de%20uso%20de%20grande%20quantidade%20deste%20medicamento%2C%20procure%20rapidamente%20socorro%20m%26%23xE9%3Bdico%20e%20leve%20a%20embalagem%20ou%20bula%20do%20medicamento%2C%20se%20poss%26%23xED%3Bvel.%20Ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%20%3Cbr%3E%20Venda%20sob%20prescri%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica.%3Cbr%3E%20M.S.%3A%201.0043.1103%3Cbr%3E%20Farm.%20Resp.%3A%20Dra.%20S%26%23xF4%3Bnia%20Albano%20Badar%26%23xF3%3B%20%26%23x96%3B%20CRF-SP%2019.258%3Cbr%3E%20%3Cbr%3E%20Fabricado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Rod.%20Pres.%20Castelo%20Branco%2C%20km%2035%2C6%20%26%23x2013%3B%20Itapevi%20%26%23x96%3B%20SP%3Cbr%3E%20%3Cbr%3E%20Registrado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Av.%20Vereador%20Jos%26%23xE9%3B%20Diniz%2C%203.465%20%26%23x2013%3B%20S%26%23xE3%3Bo%20Paulo%20%26%23x2013%3B%20SP%3Cbr%3E%20CNPJ%3A%2061.190.096%2F0001-92%3Cbr%3E%20Ind%26%23xFA%3Bstria%20Brasileira%3Cbr%3E%20%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EData%20da%20bula%3C%2Fh2%3E%0A%3Cp%3E08%2F04%2F2015%3C%2Fp%3E%0A
Ame: Não
ApresentarPrecoDePor: Sim
custom_label_0: campanha
AverageRating: 4.5
TotalRating: 11
MedicamentoControlado: Não
Cashback: Não
Antibiotico: Não
Generico: Sim